
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-manuscript.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Pharmacological characterization of mGlu1 receptors in cerebellar granule cells reveals biased agonism - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="D0BD41E4AC192A4500003A9701616166.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="nihpa" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC4387075/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387075/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Neuropharmacology" /><meta name="citation_title" content="Pharmacological characterization of mGlu1 receptors in cerebellar granule cells reveals biased agonism" /><meta name="citation_author" content="Hannah A. Hathaway" /><meta name="citation_author_institution" content="Department of Pharmacology and Physiology, Georgetown University, Washington, DC 20057, USA" /><meta name="citation_author" content="Sergey Pshenichkin" /><meta name="citation_author_institution" content="Department of Pharmacology and Physiology, Georgetown University, Washington, DC 20057, USA" /><meta name="citation_author" content="Ewa Grajkowska" /><meta name="citation_author_institution" content="Department of Pharmacology and Physiology, Georgetown University, Washington, DC 20057, USA" /><meta name="citation_author" content="Tara Gelb" /><meta name="citation_author_institution" content="Department of Pharmacology and Physiology, Georgetown University, Washington, DC 20057, USA" /><meta name="citation_author" content="Andrew C. Emery" /><meta name="citation_author_institution" content="Section on Molecular Neuroscience, National Institute of Mental Health IRP, Bldg 49, Room 5A27. Bethesda, MD 20892" /><meta name="citation_author" content="Barry B. Wolfe" /><meta name="citation_author_institution" content="Department of Pharmacology and Physiology, Georgetown University, Washington, DC 20057, USA" /><meta name="citation_author" content="Jarda T. Wroblewski" /><meta name="citation_author_institution" content="Department of Pharmacology and Physiology, Georgetown University, Washington, DC 20057, USA" /><meta name="citation_publication_date" content="2015/06" /><meta name="citation_volume" content="93" /><meta name="citation_firstpage" content="199" /><meta name="citation_doi" content="10.1016/j.neuropharm.2015.02.007" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC4387075/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC4387075/" /><meta name="citation_pmid" content="25700650" /><meta name="DC.Title" content="Pharmacological characterization of mGlu1 receptors in cerebellar granule cells reveals biased agonism" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="NIH Public Access" /><meta name="DC.Contributor" content="Hannah A. Hathaway" /><meta name="DC.Contributor" content="Sergey Pshenichkin" /><meta name="DC.Contributor" content="Ewa Grajkowska" /><meta name="DC.Contributor" content="Tara Gelb" /><meta name="DC.Contributor" content="Andrew C. Emery" /><meta name="DC.Contributor" content="Barry B. Wolfe" /><meta name="DC.Contributor" content="Jarda T. Wroblewski" /><meta name="DC.Date" content="2015 Jun" /><meta name="DC.Identifier" content="10.1016/j.neuropharm.2015.02.007" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Pharmacological characterization of mGlu1 receptors in cerebellar granule cells reveals biased agonism" /><meta property="og:type" content="article" /><meta property="og:description" content="The majority of existing research on the function of metabotropic glutamate (mGlu) receptor 1 focuses on G protein-mediated outcomes. However, similar to other G protein-coupled receptors (GPCR), it is becoming apparent that mGlu[1]  receptor signaling ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387075/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4387075/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC4387075
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC4387075/pdf/nihms665032.pdf" class="int-view">PDF (664K)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/4387075/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/4387075/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="4387075" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4387075%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="NBDL1uFYMDKNPOpLO14Gp6tpsMVZ7Ew8t3B1pHXGwCsRgHZFsKnJYpxvuaWJyFh5">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4387075%2F&amp;text=Pharmacological%20characterization%20of%20mGlu1%20receptors%20in%20cerebellar%20granule%20cells%20reveals%20biased%20agonism" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4387075%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387075/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC4387075/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/25700650/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC4387075/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/25700650/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC4387075/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/4387075/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC4387075
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-nihpa.png" alt="Logo of nihpa" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="https://www.hhs.gov/open/public-access-guiding-principles/index.html" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div><span id="pmcmata">Neuropharmacology.</span> Author manuscript; available in PMC 2016 Jun 1.</div><div></div><div class="final-form"><em>Published in final edited form as:</em></div><div class="final-citation"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=25700650" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access">Neuropharmacology. 2015 Jun; 93: 199–208. </a></div><span class="fm-vol-iss-date">Published online 2015 Feb 17. </span> <span class="doi"><span>doi: </span><a href="//doi.org/10.1016%2Fj.neuropharm.2015.02.007" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1016/j.neuropharm.2015.02.007</a></span></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC4387075</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS665032</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/25700650">25700650</a></div></div></div><h1 class="content-title">Pharmacological characterization of mGlu1 receptors in cerebellar granule cells reveals biased agonism</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Hathaway%20HA%5BAuthor%5D" class="affpopup" co-rid="_co_idm140440798761712" co-class="co-affbox">Hannah A. Hathaway</a>,<sup>a</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Pshenichkin%20S%5BAuthor%5D" class="affpopup" co-rid="_co_idm140440761620896" co-class="co-affbox">Sergey Pshenichkin</a>,<sup>a</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Grajkowska%20E%5BAuthor%5D" class="affpopup" co-rid="_co_idm140440763508384" co-class="co-affbox">Ewa Grajkowska</a>,<sup>a</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Gelb%20T%5BAuthor%5D" class="affpopup" co-rid="_co_idm140440758831008" co-class="co-affbox">Tara Gelb</a>,<sup>a</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Emery%20AC%5BAuthor%5D" class="affpopup" co-rid="_co_idm140440758829024" co-class="co-affbox">Andrew C. Emery</a>,<sup>b</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wolfe%20BB%5BAuthor%5D" class="affpopup" co-rid="_co_idm140440758827040" co-class="co-affbox">Barry B. Wolfe</a>,<sup>a</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wroblewski%20JT%5BAuthor%5D" class="affpopup" co-rid="_co_idm140440758825056" co-class="co-affbox">Jarda T. Wroblewski</a><sup>a</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140440798761712"><h3 class="no_margin">Hannah A. Hathaway</h3><p><sup>a</sup>Department of Pharmacology and Physiology, Georgetown University, Washington, DC 20057, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Hathaway%20HA%5BAuthor%5D">Hannah A. Hathaway</a></div></div><div id="_co_idm140440761620896"><h3 class="no_margin">Sergey Pshenichkin</h3><p><sup>a</sup>Department of Pharmacology and Physiology, Georgetown University, Washington, DC 20057, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Pshenichkin%20S%5BAuthor%5D">Sergey Pshenichkin</a></div></div><div id="_co_idm140440763508384"><h3 class="no_margin">Ewa Grajkowska</h3><p><sup>a</sup>Department of Pharmacology and Physiology, Georgetown University, Washington, DC 20057, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Grajkowska%20E%5BAuthor%5D">Ewa Grajkowska</a></div></div><div id="_co_idm140440758831008"><h3 class="no_margin">Tara Gelb</h3><p><sup>a</sup>Department of Pharmacology and Physiology, Georgetown University, Washington, DC 20057, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Gelb%20T%5BAuthor%5D">Tara Gelb</a></div></div><div id="_co_idm140440758829024"><h3 class="no_margin">Andrew C. Emery</h3><p><sup>b</sup>Section on Molecular Neuroscience, National Institute of Mental Health IRP, Bldg 49, Room 5A27. Bethesda, MD 20892</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Emery%20AC%5BAuthor%5D">Andrew C. Emery</a></div></div><div id="_co_idm140440758827040"><h3 class="no_margin">Barry B. Wolfe</h3><p><sup>a</sup>Department of Pharmacology and Physiology, Georgetown University, Washington, DC 20057, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wolfe%20BB%5BAuthor%5D">Barry B. Wolfe</a></div></div><div id="_co_idm140440758825056"><h3 class="no_margin">Jarda T. Wroblewski</h3><p><sup>a</sup>Department of Pharmacology and Physiology, Georgetown University, Washington, DC 20057, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wroblewski%20JT%5BAuthor%5D">Jarda T. Wroblewski</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140440761751360_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140440761751360_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140440761751360_ai" style="display:none"><div class="fm-affl" id="A1"><sup>a</sup>Department of Pharmacology and Physiology, Georgetown University, Washington, DC 20057, USA</div><div class="fm-affl" id="A2"><sup>b</sup>Section on Molecular Neuroscience, National Institute of Mental Health IRP, Bldg 49, Room 5A27. Bethesda, MD 20892</div><div id="FN1">To whom correspondence should be addressed: Dept. of Pharmacology, Georgetown University, 3900 Reservoir Road, NW, Med-Dent Bldg SW406, Washington, D. C. 20057, Tel.: 202-687-1566; Fax: 202-687-2585, <a href="mailto:dev@null" data-email="ude.nwotegroeg@23hah" class="oemail">ude.nwotegroeg@23hah</a></div></div><div class="fm-article-notes half_rhythm"></div><div class="permissions half_rhythm hide" id="idm140440761751360_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">PMC Copyright notice</a> </div><div><a href="#FN2">Publisher's Disclaimer</a></div></div></div><div id="pmclinksbox" class="links-box whole_rhythm" role="complementary" aria-label="Related or updated information about this article."><div>The publisher's final edited version of this article is available  at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=25700650" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access">Neuropharmacology</a></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplemental Figure 1. Overnight incubation with granule cells reduces the concentration of extracellular glutamate Increasing concentrations of glutamate were added to 7DIV cerebellar granule cells in K5 media and incubated at 37&#x000b0;C in 5% CO<sub>2</sub>. The following day this cultured conditioned media was removed and the apparent concentration of glutamate was assayed using the Amplex Red glutamic acid assay kit (Molecular Probes, Eugene, OR) and resulting fluorescence (proportional to glutamate concentration) was measured according to the manufacturer&#x02019;s instructions. Relative fluorescent units of culture conditioned glutamate (open symbols) are compared to the signal obtained from glutamate freshly diluted in K5 media (closed symbols). In the culture conditioned media, the signal relative to an EC<sub>50</sub> glutamate concentration (76 &#x003bc;M) is equivalent to the signal obtained by 19 &#x003bc;M freshly prepared glutamate, as indicated by the grey arrows. For each point, background fluorescence was corrected by subtracting values derived from controls lacking glutamate. Data are means from 2 experiments with error bars representing S.D.</div><div><a href="/pmc/articles/PMC4387075/bin/NIHMS665032-supplement-supplement_1.pdf" data-ga-action="click_feat_suppl">NIHMS665032-supplement-supplement_1.pdf</a><span style="color:gray"> (29K)</span></div><div class="small guid">GUID: 16751070-FA5D-45EB-9D29-1DF5DC2F7B7B</div></div></dd></dl></div><div id="abstract-a.l.b.r" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.l.b.rtitle">Abstract</h2><!--article-meta--><div><p id="P1" class="p p-first-last">The majority of existing research on the function of metabotropic glutamate (mGlu) receptor 1 focuses on G protein-mediated outcomes. However, similar to other G protein-coupled receptors (GPCR), it is becoming apparent that mGlu<sub>1</sub> receptor signaling is multi-dimensional and does not always involve G protein activation. Previously, in transfected CHO cells, we showed that mGlu<sub>1</sub> receptors activate a G protein-independent, &#x003b2;-arrestin-dependent signal transduction mechanism and that some mGlu<sub>1</sub> receptor ligands were incapable of stimulating this response. Here we set out to investigate the physiological relevance of these findings in a native system using primary cultures of cerebellar granule cells. We tested the ability of a panel of compounds to stimulate two mGlu1 receptor-mediated outcomes: (1) protection from decreased cell viability after withdrawal of trophic support and (2) G protein-mediated phosphoinositide (PI) hydrolysis. We report that the commonly used mGlu<sub>1</sub> receptor ligands quisqualate, DHPG, and ACPD are completely biased towards PI hydrolysis and do not induce mGlu<sub>1</sub> receptor-stimulated neuroprotection. On the other hand, endogenous compounds including glutamate, aspartate, cysteic acid, cysteine sulfinic acid, and homocysteic acid stimulate both responses. These results show that some commonly used mGlu<sub>1</sub> receptor ligands are biased agonists, stimulating only a fraction of mGlu<sub>1</sub> receptor-mediated responses in neurons. This emphasizes the importance of utilizing multiple agonists and assays when studying GPCR function.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">metabotropic glutamate receptor 1, biased agonism, glutamate, quisqualate, DHPG, cerebellar granule cells</span></div></div><div id="S1" class="tsec sec"><h2 class="head no_bottom_margin" id="S1title">1. Introduction</h2><p id="P2" class="p p-first">G protein-coupled receptors (GPCRs) make up the largest class of membrane receptors and are the target of the majority of current pharmaceuticals (<a href="#R31" rid="R31" class=" bibr popnode">Reiter et al., 2012</a>). Classically, stimulation of these receptors causes activation of their associated G proteins and production of second messengers. Various GPCRs also partake in G protein independent signal transduction, the most studied of which is &#x003b2;-arrestin-dependent signaling. These G protein-independent cascades activate downstream enzymes in temporally and spatially different patterns compared to G protein-dependent activation (<a href="#R6" rid="R6" class=" bibr popnode">DeWire et al., 2007</a>). Thus, it is not surprising that G protein-independent signals result in cellular and physiological outcomes that are distinct from those mediated by G protein stimulation (<a href="#R18" rid="R18" class=" bibr popnode">Luttrell and Gesty-Palmer, 2010</a>).</p><p id="P3">As we understand more about the complexities of GPCR signaling it is apparent that receptor activation is not as simple as on and off (<a href="#R30" rid="R30" class=" bibr popnode">Rajagopal et al., 2010</a>). Indeed, many GPCR ligands exhibit <em>biased agonism</em>: unequal ability (i.e. efficacies) to stimulate different responses mediated by a single receptor (<a href="#R29" rid="R29" class=" bibr popnode">Rajagopal et al., 2011</a>). Because of the multidimensionality of GPCR signaling and agonism, it is important to assay numerous agonists and responses when characterizing GPCR signaling. Such rigorous investigations not only provide a more complete picture of receptor function, but also provide the framework for development of selective therapeutics that potentially reduce side effects by specifically activating one receptor outcome (<a href="#R18" rid="R18" class=" bibr popnode">Luttrell and Gesty-Palmer, 2010</a>; <a href="#R40" rid="R40" class=" bibr popnode">Violin et al., 2014</a>).</p><p id="P4">Metabotropic glutamate (mGlu) receptors are GPCRs primarily expressed in the nervous system. mGlu receptors are divided into three groups based on sequence homology and G protein-coupling (<a href="#R3" rid="R3" class=" bibr popnode">Conn and Pin, 1997</a>; <a href="#R24" rid="R24" class=" bibr popnode">Nakanishi, 1992</a>). Group I mGlu receptors, which include mGlu<sub>1</sub> receptors and mGlu<sub>5</sub> receptors, are coupled to G&#x003b1;q proteins. Thus, activation of group I mGlu receptors stimulates phospholipase C, resulting in hydrolysis of PIP<sub>2</sub> and formation of the second messengers IP<sub>3</sub> and DAG (<a href="#R10" rid="R10" class=" bibr popnode">Ferraguti et al., 2008</a>). Additionally, glutamatergic activation of mGlu<sub>1</sub> receptors stimulates a G protein-independent, &#x003b2;-arrestin-dependent signal transduction mechanism that protects mGlu<sub>1</sub> receptor-transfected CHO cells from toxicity after serum withdrawal (<a href="#R9" rid="R9" class=" bibr popnode">Emery et al., 2010</a>). Similar increases in cell viability upon glutamate treatment occur in multiple cell types and are dependent on mGlu<sub>1</sub> receptor activation (<a href="#R12" rid="R12" class=" bibr popnode">Gelb et al., 2014</a>; <a href="#R28" rid="R28" class=" bibr popnode">Pshenichkin et al., 2008</a>). Activation of the protective, &#x003b2;-arrestin-dependent pathway does not occur with exogenous, group I mGlu receptor-preferring agonists (e.g. quisqualate), but only with endogenous agonists such as glutamate and aspartate (<a href="#R8" rid="R8" class=" bibr popnode">Emery et al., 2012</a>). These findings suggest that activation of mGlu<sub>1</sub> receptors may protect neurons from apoptosis. As targeting of mGlu<sub>1</sub> receptors could be a potential neuroprotective strategy (<a href="#R2" rid="R2" class=" bibr popnode">Caraci et al., 2012</a>), it is vital to fully characterize mGlu<sub>1</sub> receptor signaling in native systems.</p><p id="P5" class="p p-last">The purpose of this study was to investigate mGlu<sub>1</sub> receptor signaling in a physiologically relevant model. Primary cultures of cerebellar granule cells were utilized as mGlu<sub>1</sub> receptors are highly expressed in these neurons (<a href="#R33" rid="R33" class=" bibr popnode">Santi et al., 1994</a>). To maximize culture viability, granule cells must be maintained in chronic depolarizing conditions (&#x0003e;20 mM potassium) since granule cells undergo apoptosis in concentrations of potassium that are physiological (5 mM). Granule cell death in this model occurs quickly and is reproducible, which is why the potassium removal paradigm is commonly used to study neurotoxicity and neuroprotection (see <a href="#R4" rid="R4" class=" bibr popnode">Contestabile 2002</a> for thorough review). Using primary cultures of cerebellar granule cells we characterized mGlu<sub>1</sub> receptors using a panel of eight mGlu<sub>1</sub> receptor ligands (glutamate, aspartate, cysteic acid, homocysteic acid, cysteine sulfinic acid, quisqualate, DHPG, and ACPD). The response to each ligand was determined by two mGlu<sub>1</sub> receptor-dependent outcomes: protection from toxicity after potassium removal and phosphoinositide (PI) hydrolysis. We report here that native mGlu<sub>1</sub> receptors exhibit biased agonism in primary neuronal cultures. These findings confirm the neuroprotective potential of mGlu<sub>1</sub> receptors and emphasize the need for further drug design endeavors to selectively activate this protective mechanism while potentially reducing side effects.</p></div><div id="S2" class="tsec sec"><h2 class="head no_bottom_margin" id="S2title">2. Methods</h2><div id="S3" class="sec sec-first"><h3 id="S3title">2.1 &#x02013; Materials</h3><p id="P6" class="p p-first-last">Neurobasal (NB) media, 2 M KCl, B27 supplement, L-glutamine, and gentamicin were purchased from Life Technologies (Carlsbad, CA, USA). Receptor agonists (glutamate, aspartate, quisqualate, 3,5-dihydroxyphenylglycine (DHPG), (1S,3R)-1- aminocyclopentane-1,3-dicarboxylic acid (ACPD), N-methyl-D-aspartate (NMDA)), receptor antagonists (YM298198-HCl, CPCCOEt, JNJ16259685, MPEP, MK801, CFM2, MCCG, MAP4) were purchased from Tocris Bioscience (Bristol, United Kingdom). All receptor agonists were prepared in equimolar sodium hydroxide (VWR, Radnor, PA, USA) and adjusted to pH 7.3 &#x02013; 7.5. All antagonists were diluted in DMSO (Fisher Scientific, Pittsburgh, PA, USA), except for MPEP, which was prepared in water. Glutamate pyruvate transaminase (GPT) was obtained from Roche (Indianapolis, IN, USA). All other chemicals were purchased from Sigma (St. Louis, MO, USA).</p></div><div id="S4" class="sec"><h3 id="S4title">2.2 &#x02013; Cell cultures</h3><p id="P7" class="p p-first-last">Primary cultures of cerebellar granule neurons were prepared as described previously (<a href="#R43" rid="R43" class=" bibr popnode">Wroblewski et al., 1985</a>) using cerebella dissected from P7 Sprague-Dawley rat pups. Cerebellar granule cells were plated in 100 &#x003bc;l at a density of 8&#x000d7;10<sup>5</sup> cells/cm<sup>2</sup> on Nunclon Delta Surface 96-well plates (VWR) coated with poly-L-lysine. Cytosine arabinoside (10 &#x003bc;M) was added the day after plating to prevent growth of non-neural cells. Cultures were maintained at 37&#x000b0;C in 5% CO<sub>2</sub> in culture media (Neurobasal media containing 100 &#x003bc;g/ml gentamicin, 2 mM glutamine, 2% B27 supplement, and 25 mM KCl) for 5 to 6 days in vitro (DIV). For experimentation, granule cells were maintained overnight at 37&#x000b0;C in 5% CO<sub>2</sub> in Neurobasal containing 100 &#x003bc;g/ml gentamicin and either 25 mM KCl (K25 conditions) or 5 mM KCl (K5 conditions). Granule cells cultured under these conditions express high levels of mGlu<sub>1</sub> receptors (<a href="#R28" rid="R28" class=" bibr popnode">Pshenichkin et al., 2008</a>).</p></div><div id="S5" class="sec"><h3 id="S5title">2.3 &#x02013; Cell viability assays</h3><p id="P8" class="p p-first-last">Cell viability was measured by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay where formation of the colored product is proportional to the number of viable cells (<a href="#R23" rid="R23" class=" bibr popnode">Mosmann, 1983</a>). Cerebellar granule cells were maintained for 5 days in vitro in culture media, and then media was removed and replaced with 200 &#x003bc;l K5 media containing drugs in 1% DMSO. Neurons were incubated with drugs overnight. The next day, 50 &#x003bc;l of 1.5 mg/ml MTT in K5 media was added to each well and incubated at 37&#x000b0;C for 60 minutes. MTT was then removed and the colored formazan product was dissolved in 65 &#x003bc;l/well DMSO. Absorbance of each well was measured at 570 nm by spectrophotometer (EnVision, Perkin-Elmer, Waltham, MA, USA). Cell viability is expressed as either percent of K25 (positive control), or as percent of glutamate efficacy.</p></div><div id="S6" class="sec"><h3 id="S6title">2.4 &#x02013; Measurement of PI hydrolysis</h3><p id="P9" class="p p-first-last">PI hydrolysis was measured using scintillation proximity assay (SPA) beads as previously described (<a href="#R9" rid="R9" class=" bibr popnode">Emery et al., 2010</a>). After 6-7 days in vitro, culture media was replaced with K5 media containing 0.625 &#x003bc;Ci/well myo-[<sup>3</sup>H]inositol (Perkin Elmer) and incubated overnight. Media was then removed and cells were treated with drugs in 0.5% DMSO for 1 hour at 37&#x000b0;C in 100 &#x003bc;l/well Locke&#x02019;s buffer (156 mM NaCl, 5.6 mM KCl, 3.6 mM NaHCO<sub>3</sub>, 1 mM MgCl<sub>2</sub>, 1.3 mM CaCl<sub>2</sub>, 5.6 mM glucose and 20 mM HEPES, pH 7.4) with 20 mM LiCl to block the degradation of inositol phosphates. Drug treatments were then removed and inositol phosphates were extracted in 60 &#x003bc;l/well ice cold 10 mM formic acid for 30 minutes. 40 &#x003bc;l/well were then transferred to a scintillation plate containing 1 mg/well YSi poly-lysine SPA beads (Perkin-Elmer) and incubated at room temperature for 1 hour with vigorous shaking. After 10 hours of incubation with SPA beads, inositol phosphates were detected by scintillation counting.</p></div><div id="S7" class="sec"><h3 id="S7title">2.5 &#x02013; Stability of agonists in media</h3><p id="P10" class="p p-first-last">Agonists were bioassayed after 24-hour exposure to cerebellar granule cells to establish prolonged stability. Agonists were &#x0201c;cultured conditioned&#x0201d; by incubating agonists in K5 media with cerebellar granule cells for 24 hours. Culture conditioned agonists in K5 media were collected, 20 mM LiCl was added, and agonist were applied to separate cultures of cerebellar granule cells that were previously labeled with 0.625 &#x003bc;Ci/well myo- [<sup>3</sup>H]inositol. Resulting PI hydrolysis in response to culture conditioned agonists was compared in parallel to PI hydrolysis caused by agonists freshly prepared in K5 media with 20 mM LiCl.</p></div><div id="S8" class="sec sec-last"><h3 id="S8title">2.6 &#x02013; Curve fittings and statistical analysis</h3><p id="P11" class="p p-first-last">Dose-response curves were modeled via four-parameter nonlinear regression using GraphPad Prism 6 software (La Jolla, CA, USA). For each agonist the bottom parameter was constrained to the corresponding basal value (K5 for viability, Locke for PI hydrolysis). Differences between dose-response curves were determined by comparing E<sub>max</sub> and EC<sub>50</sub> values, for experiments with data that could not be fit to the non-linear regression model significant effects were determined by comparing one maximal concentration of ligand to basal levels. Each experiment was performed at least two times using independent preparations of granule cells, with measurements taken in duplicate within each experiment. Statistical significance was defined as p-value &#x0003c; 0.05 by Student&#x02019;s t-test or Sidak-corrected multiple comparisons following one- or two-way ANOVA. All statistical analysis was performed using GraphPad Prism 6 software.</p></div></div><div id="S9" class="tsec sec"><h2 class="head no_bottom_margin" id="S9title">3. Results</h2><div id="S10" class="sec sec-first"><h3 id="S10title">3.1 &#x02013; Glutamate increases viability of granule cells in K5 conditions via activation of mGlu<sub>1</sub> receptors</h3><p id="P12" class="p p-first-last">To maximize cell viability, primary cultures of cerebellar granule neurons are maintained in media supplemented with high potassium (K25) (<a href="#R11" rid="R11" class=" bibr popnode">Gallo et al., 1987</a>). Decreasing potassium to 5 mM (K5) reduced granule cell viability and after 16 hours the amount of viable cells in K5 cultures was approximately 35% of that in K25 cultures (<a href="/pmc/articles/PMC4387075/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>). Addition of glutamate to K5 media caused a concentration-dependent increase in granule cell viability, with an EC<sub>50</sub> of 76 &#x003bc;M and a maximum effect of 65% of the viability observed in K25 cultures (p&#x0003c;0.001 compared to K5). This increase in cell viability with glutamate treatment was significantly blocked by the mGlu<sub>1</sub> receptor noncompetitive antagonist JNJ16259685 (300 &#x003bc;M, <a href="/pmc/articles/PMC4387075/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1A</span></a>; p=0.004), with an IC<sub>50</sub> of 19.8 &#x003bc;M (<a href="/pmc/articles/PMC4387075/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1B</span></a>) and by the mGlu<sub>1</sub> receptor noncompetitive CPCCOEt (300 &#x003bc;M, <a href="/pmc/articles/PMC4387075/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1C</span></a>; p=0.007) with an IC<sub>50</sub> of 123 &#x003bc;M (<a href="/pmc/articles/PMC4387075/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1D</span></a>). However, the increase in granule cell viability mediated by 1 mM glutamate was not significantly reduced by antagonism of mGlu<sub>5</sub> receptors (10 &#x003bc;M MPEP), group II mGlu receptors (100 &#x003bc;M MCCG), group III mGlu receptors (100 &#x003bc;M MAP4), AMPA receptors (10 &#x003bc;M CFM2), or NMDA receptors (1 &#x003bc;M MK801) (<a href="/pmc/articles/PMC4387075/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1E</span></a>). Taken together, these data support the hypothesis that the glutamate-dependent increase in viability of granule cells in K5 is specifically mediated by activation of mGlu<sub>1</sub> receptors.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC4387075/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140440761736320"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms665032f1.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms665032f1.jpg" src="/pmc/articles/PMC4387075/bin/nihms665032f1.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140440761736320"><a target="object" rel="noopener" href="/pmc/articles/PMC4387075/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC4387075/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Glutamate increases viability of cerebellar granule cells in K5 via mGlu<sub>1</sub> receptor activation</strong><p>Cerebellar granule cells were maintained in K25 media for 5 days in vitro and then subjected to potassium withdrawal for 16 hours. Cell viability was determined by MTT assay. Drugs were added to K5 at the time of potassium withdrawal. (A) Addition of glutamate to K5 conditions increased cell viability and this neuroprotective effect of glutamate was inhibited by addition of the mGlu<sub>1</sub> receptor-selective noncompetitive antagonist JNJ16259685 (300 &#x003bc;M). (B) Addition of JNJ16259685 to a maximal concentration of glutamate (1 mM) resulted in a concentration-dependent decrease in the neuroprotective action of glutamate, with an IC<sub>50</sub> of 19.8 &#x003bc;M. (C-D) The neuroprotective effect of glutamate was also inhibited by the mGlu<sub>1</sub> receptor noncompetitive antagonist CPCCOEt (300 &#x003bc;M), with an IC<sub>50</sub> of 123 &#x003bc;M. (E) The glutamate-induced increase in granule cell viability was not affected by antagonists to mGlu<sub>5</sub> receptors (MPEP, 10 &#x003bc;M), group II mGlu receptors (MCCG, 100 &#x003bc;M), group III mGlu receptors (MAP4, 100 &#x003bc;M), AMPA receptors (CFM2, 10 &#x003bc;M), or NMDA receptors (MK801, 1 &#x003bc;M). All data are represented as percent of K25 control and are means of at least 3 independent experiments with error bars corresponding to S.E.M. Statistical significance defined as p&#x0003c;0.05 (*) by ANOVA followed by Sidak post-test to account for multiple comparison.</p></div></div></div></div><div id="S11" class="sec"><h3 id="S11title">3.2 &#x02013; Increase in viability of K5 cultures with NMDA treatment requires mGlu<sub>1</sub> receptor activation and extracellular glutamate</h3><p id="P13" class="p p-first-last">We found that NMDA receptor antagonism did not significantly reduce glutamateinduced protection from K5 toxicity, although there are numerous previous studies reporting that application of NMDA increases viability of granule cells cultured in K5 conditions (<a href="#R1" rid="R1" class=" bibr popnode">Bal&#x000e1;zs et al., 1988</a>; <a href="#R5" rid="R5" class=" bibr popnode">Copani et al., 1995</a>; <a href="#R44" rid="R44" class=" bibr popnode">Xifr&#x000f3; et al., 2014</a>). To address this issue, we tested the ability of NMDA to increase the viability of cerebellar granule cells in K5 cultures. In agreement with previous reports, NMDA caused a concentration-dependent increase in granule cell viability with an EC<sub>50</sub> of 106 &#x003bc;M and an E<sub>max</sub> of 73% of the cell viability in K25 cultures (p=0.02 compared to K5, <a href="/pmc/articles/PMC4387075/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2A</span></a>). The increase in granule cell viability mediated by 1 mM NMDA was significantly inhibited by the NMDA receptor antagonist MK801 (1 &#x003bc;M) (<a href="/pmc/articles/PMC4387075/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2B</span></a>). Additionally, the effect of NMDA was blocked by mGlu<sub>1</sub> receptor antagonism (300 &#x003bc;M JNJ16259685, <a href="/pmc/articles/PMC4387075/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2B</span></a>). These data imply that the protection mediated by NMDA requires activation of both NMDA receptors and mGlu<sub>1</sub> receptors. One possible explanation of this result is that NMDA receptor stimulation induces depolarization of granule neurons, resulting in release of glutamate that subsequently activates mGlu<sub>1</sub> receptors. To test this, 1 mM NMDA in K5 was co-applied with glutamate pyruvate transaminase (GPT). In the presence of high concentrations of pyruvate, GPT enzymatically converts glutamate and pyruvate to &#x003b1;-ketoglutarate and alanine, thus effectively depleting extracellular glutamate. Addition of 1 mM NMDA to K5 significantly increased granule cell viability in the presence of 10 mM pyruvate, however NMDA was no longer effective in the presence of 10 mM pyruvate + 35 &#x003bc;g/ml GPT (<a href="/pmc/articles/PMC4387075/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2C</span></a>). These results indicate that NMDA treatment increases the viability of granule cells in K5 due to an NMDA receptor-mediated increase in extracellular glutamate, which then activates mGlu<sub>1</sub> receptors. This further supports the conclusion that glutamate-stimulated protection from decreased granule cell viability upon potassium withdrawal does not appear to involve NMDA receptors, but instead specifically requires mGlu<sub>1</sub> receptor activation.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC4387075/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140440761731120"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms665032f2.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms665032f2.jpg" src="/pmc/articles/PMC4387075/bin/nihms665032f2.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140440761731120"><a target="object" rel="noopener" href="/pmc/articles/PMC4387075/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC4387075/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Increase in viability of granule cells in K5 with NMDA treatment requires NMDA receptors, mGlu<sub>1</sub> receptors, and extracellular glutamate</strong><p>Cerebellar granule cells were maintained in K25 media for 5 days in vitro and then subjected to decreased potassium conditions (K5) for 16 hours. Cell viability was determined by MTT assay. Drugs were added to K5 at the time of potassium withdrawal. (A) Addition of NMDA to K5 conditions increases granule cell viability (E<sub>max</sub>: 72% of K25 control, EC<sub>50</sub>: 105.5 &#x003bc;M). (B) NMDA effect is inhibited by both antagonism of either NMDA receptors (MK801, 1 &#x003bc;M) or mGlu<sub>1</sub> receptors (JNJ16259685, 300 &#x003bc;M). (C) Enzymatic depletion of extracellular glutamate (using glutamate pyruvate transaminase, GPT) also inhibited NMDA protection from K5 toxicity. Data are means of at least 3 independent experiments with error bars corresponding to S.E.M. Statistical significance defined as p&#x0003c;0.05 (*) by ANOVA followed by Sidak post-test to account for multiple comparisons.</p></div></div></div></div><div id="S12" class="sec"><h3 id="S12title">3.3 &#x02013; Only a subset of mGlu<sub>1</sub> receptor agonists protect cerebellar granule cells from K5 toxicity</h3><p id="P14" class="p p-first">Having established a role of mGlu<sub>1</sub> receptor stimulation in increasing the viability of cerebellar granule cells, we next performed a thorough characterization of the pharmacology of this effect using multiple mGlu<sub>1</sub> receptor agonists. Similar to glutamate (<a href="/pmc/articles/PMC4387075/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3A</span></a>, round symbols), addition of other endogenous compounds (<a href="#R36" rid="R36" class=" bibr popnode">Shi et al., 2003</a>) increased viability of granule cells in K5 conditions. Addition of aspartate to K5 media significantly increased granule cell viability (<a href="/pmc/articles/PMC4387075/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3B</span></a>, round symbols; p&#x0003c;0.001). The sulfinic acid analog of aspartate, cysteine sulfinic acid (CSA), also increased viability of granule cells in K5 (<a href="/pmc/articles/PMC4387075/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3C</span></a>, triangle symbols; p&#x0003c;0.001), as did the related compounds cysteic acid (CA, <a href="/pmc/articles/PMC4387075/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3A</span></a>, triangle symbols; p&#x0003c;0.001) and homocysteic acid (HCA, <a href="/pmc/articles/PMC4387075/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3B</span></a>, triangle symbols; p&#x0003c;0.001). We also tested three exogenous agonists commonly used to study mGlu<sub>1</sub> receptors: quisqualate, DHPG, and ACPD. Neither quisqualate (<a href="/pmc/articles/PMC4387075/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3A</span></a>, square symbols) nor DHPG (<a href="/pmc/articles/PMC4387075/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3B</span></a>, square symbols) increased viability of granule cells in K5 and dose-response curves could not be fit to these data. Addition of ACPD to K5 caused a small increase in granule cell viability and this response could be fit to a dose-response curve (<a href="/pmc/articles/PMC4387075/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3C</span></a>, square symbols); however the maximum efficacy of ACPD was not a significant increase compared to K5 alone (49 &#x000b1; 5% with ACPD compared to 42 &#x000b1; 4% in K5, p=0.23).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC4387075/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140440759638864"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms665032f3.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms665032f3.jpg" src="/pmc/articles/PMC4387075/bin/nihms665032f3.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140440759638864"><a target="object" rel="noopener" href="/pmc/articles/PMC4387075/figure/F3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC4387075/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Characterization of ability of mGlu<sub>1</sub> receptor agonists to protect cerebellar granule cells from K5 toxicity</strong><p>Cerebellar granule cells were maintained in K25 media for 5 days in vitro and then subjected to decreased potassium conditions (K5) for 16 hours. Cell viability was determined by MTT assay. Drugs were added to K5 at the time of potassium withdrawal. Cell viability was evaluated by MTT assay and is expressed as a percent of viability of cells cultured in K25 media. K5-induced toxicity was prevented by treatment with (A) glutamate, cysteic acid, (B) aspartate, homocysteic acid, and (C) cysteine sulfinic acid. Viability of cerebellar granule cells was not significantly increased by (A) quisqualate, (B) DHPG, or (C) ACPD. Agonist-dependent increases in cell viability were significantly inhibited by the mGlu<sub>1</sub> receptor antagonists JNJ16259685 (300 &#x003bc;M, panel D) or CPCCOEt (200 &#x003bc;M, panel E). Data are means of at least 3 independent experiments with error bars corresponding to S.E.M. Statistical significance defined as p&#x0003c;0.05 (*) by ANOVA followed by Sidak post-test to account for multiple comparisons.</p></div></div></div><p id="P15" class="p p-last">For each agonist that increased viability of granule cells in K5 conditions, a maximal concentration of agonist was assayed in the presence of 300 &#x003bc;M JNJ16259685 (<a href="/pmc/articles/PMC4387075/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3D</span></a>) or in the presence of 200 &#x003bc;M CPCCOEt (<a href="/pmc/articles/PMC4387075/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3E</span></a>). These mGlu<sub>1</sub> receptor antagonists significantly blocked the increase in granule cell viability induced by 1 mM glutamate, 1 mM CA, 1 mM aspartate, 1 mM HCA, and 1 mM CSA (<a href="/pmc/articles/PMC4387075/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3D-E</span></a>).</p></div><div id="S13" class="sec sec-last"><h3 id="S13title">3.4 &#x02013; mGlu<sub>1</sub> receptors exhibit biased agonism in primary cultures of cerebellar granule cells</h3><p id="P16" class="p p-first">Only a subset of ligands that activate mGlu<sub>1</sub> receptors protected cerebellar granule cells from K5 toxicity; however, in previous reports these non-protective ligands stimulate PI hydrolysis in neurons (<a href="#R34" rid="R34" class=" bibr popnode">Schoepp et al., 1994</a>; <a href="#R38" rid="R38" class=" bibr popnode">Toms et al., 1995</a>). This suggests that biased agonism may exist at mGlu<sub>1</sub> receptors. To test this hypothesis, we examined the ability of these non-protective compounds to activate mGlu<sub>1</sub> receptor-mediated PI hydrolysis. In cerebellar granule cells maintained overnight in K5 conditions, addition of 1 mM glutamate caused a robust increase in PI hydrolysis compared to granule cells treated with DMSO vehicle (314% of basal, p&#x0003c;0.001; <a href="/pmc/articles/PMC4387075/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4A</span></a>). This increase in PI hydrolysis was completely inhibited by the mGlu<sub>1</sub> receptor antagonist JNJ16259685 (300 &#x003bc;M), and was not affected by the mGlu<sub>5</sub> receptor antagonist MPEP (10 &#x003bc;M) (<a href="/pmc/articles/PMC4387075/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4A</span></a>). These data suggest that mGlu<sub>1</sub> receptor stimulation is solely responsible for glutamatedependent PI hydrolysis in cerebellar granule cells.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC4387075/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140440759633904"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms665032f4.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms665032f4.jpg" src="/pmc/articles/PMC4387075/bin/nihms665032f4.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140440759633904"><a target="object" rel="noopener" href="/pmc/articles/PMC4387075/figure/F4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC4387075/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Characterization of mGlu<sub>1</sub> receptor agonist-mediated PI hydrolysis in cerebellar granule cells</strong><p>Cerebellar granule cells were maintained in K25 media for 6-7 days in vitro and then membrane phosphoinositides were labeled by overnight incubation in K5 plus 3Hinositol. K5 media was then removed and PI hydrolysis was measured in response to agonists and antagonists diluted in Locke&#x02019;s medium containing 0.5% DMSO vehicle. (A) Addition of 1 mM glutamate caused a robust increase in PI hydrolysis in cerebellar granule cells. Glutamate-induced PI hydrolysis was inhibited by mGlu<sub>1</sub> receptor-selective antagonist JNJ16259685 but not by mGlu<sub>5</sub> receptor antagonist MPEP. PI hydrolysis was increased in a dose-dependent manner by (B) glutamate, quisqualate, cysteic acid, (C) aspartate, DHPG, homocysteic acid, (D) ACPD, and cysteine sulfinic acid. Data are means &#x000b1; S.E.M. of 3 independent experiments (panel A) or means &#x000b1; S.D. of at least 2 independent experiments (panels B-D). Statistical significance defined as p&#x0003c;0.05 (*) by ANOVA followed by Sidak post-test to account for multiple comparisons.</p></div></div></div><p id="P17">Having established that mGlu<sub>1</sub> receptor activation stimulates PI hydrolysis, we next assayed PI hydrolysis in response to a panel of compounds. All five neuroprotective agonists increased PI hydrolysis: glutamate (<a href="/pmc/articles/PMC4387075/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4B</span></a>, round symbols), aspartate (<a href="/pmc/articles/PMC4387075/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4C</span></a>, round symbols), cysteine sulfinic acid (CSA, <a href="/pmc/articles/PMC4387075/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4D</span></a>, triangle symbols), cysteic acid (CA, <a href="/pmc/articles/PMC4387075/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4B</span></a>, triangle symbols), and homocysteic acid (HCA, <a href="/pmc/articles/PMC4387075/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4C</span></a>, triangle symbols). Additionally, the non-protective ligands quisqualate (<a href="/pmc/articles/PMC4387075/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4B</span></a>, square symbols), DHPG (<a href="/pmc/articles/PMC4387075/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4C</span></a>, square symbols), and ACPD (<a href="/pmc/articles/PMC4387075/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4D</span></a>, square symbols) increased PI hydrolysis. Quisqualate was as a full agonist while DHPG and ACPD were partial agonists compared to glutamate. To confirm that PI hydrolysis elicited by quisqualate, DHPG, and ACPD is due to mGlu<sub>1</sub> receptor activation each agonist was assayed in the presence of JNJ16259685 or CPCCOEt (<a href="/pmc/articles/PMC4387075/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5</span></a>, grey bars). Both of these mGlu<sub>1</sub> receptor antagonists significantly decreased PI hydrolysis stimulated by quisqualate, DHPG, and ACPD. Additionally, the mGlu<sub>5</sub> receptor antagonist MPEP had no effect on agonist-stimulated PI hydrolysis (<a href="/pmc/articles/PMC4387075/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5</span></a>, black bars). These data confirm that the ligands investigated in this study act as mGlu<sub>1</sub> receptor agonists in cerebellar granule cell cultures.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F5" co-legend-rid="lgnd_F5"><a href="/pmc/articles/PMC4387075/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140440763839376"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms665032f5.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms665032f5.jpg" src="/pmc/articles/PMC4387075/bin/nihms665032f5.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140440763839376"><a target="object" rel="noopener" href="/pmc/articles/PMC4387075/figure/F5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F5"><div><a class="figpopup" href="/pmc/articles/PMC4387075/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5">Figure 5</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>PI hydrolysis induced by mGlu receptor-selective agonists is due to mGlu<sub>1</sub> receptor activation in cerebellar granule cells</strong><p>Cerebellar granule cells were maintained in K25 media for 6-7 days and then membrane phosphoinositides were labeled by overnight incubation in K5 plus <sup>3</sup>H-inositol. K5 media was then removed and PI hydrolysis was measured in response to agonists and antagonists diluted in Locke&#x02019;s medium containing 0.5% DMSO. Addition of quisqualate (quis, 100 &#x003bc;M), DHPG (100 &#x003bc;M), or ACPD (100 &#x003bc;M) induced a significant increase in PI hydrolysis compared to granule cells treated in Locke&#x02019;s media only (white bars). PI hydrolysis induced by all three agonists was significantly decreased by the mGlu<sub>1</sub> receptor antagonists JNJ16259685 (JNJ, 300 &#x003bc;M &#x02013; dark grey bars) or CPCCOEt (CPCC, 200 &#x003bc;M &#x02013; light grey bars). Agonist-induced PI hydrolysis was not significantly diminished by mGlu<sub>5</sub> receptor antagonism (MPEP, 10 &#x003bc;M &#x02013; black bars). Dashed line corresponds to basal PI hydrolysis in Locke + 0.5% DMSO vehicle. Data are means of at least 3 independent experiments with error bars corresponding to S.E.M. Statistical significance defined as p&#x0003c;0.05 when compared to Locke + DMSO (*) or when compared to Locke + agonist (&#x02020;) by ANOVA followed by Sidak post-test to account for multiple comparisons.</p></div></div></div><p id="P18">One possible reason quisqualate, DHPG, and ACPD cause mGlu<sub>1</sub> receptormediated PI hydrolysis in cerebellar granule cells but do not protect from K5 toxicity is that these drugs degrade over time. Viability experiments require overnight incubation while assay of PI hydrolysis requires only a short incubation with agonist (1 hour). To test the hypothesis that these non-protective mGlu<sub>1</sub> receptor ligands have a decreased stability over time, agonists were incubated with cerebellar granule cells in K5 media overnight. This culture conditioned media was then removed and added to untreated cultures of cerebellar granule cells. If prolonged incubation decreased agonist stability, then PI hydrolysis stimulated by culture conditioned agonists (<a href="/pmc/articles/PMC4387075/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6</span></a>, open symbols) would be less than that stimulated by agonists freshly prepared in K5 media (<a href="/pmc/articles/PMC4387075/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6</span></a>, closed symbols). However, we found that overnight incubation with cerebellar granule cells had no significant effect on the EC<sub>50</sub> or E<sub>max</sub> for PI hydrolysis stimulated by quisqualate (<a href="/pmc/articles/PMC4387075/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6A</span></a>), DHPG (<a href="/pmc/articles/PMC4387075/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6B</span></a>), or ACPD (<a href="/pmc/articles/PMC4387075/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6C</span></a>). Thus, the inability of these agonists to protect cerebellar granule cells from K5 toxicity cannot be explained by a loss of agonist stability.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F6" co-legend-rid="lgnd_F6"><a href="/pmc/articles/PMC4387075/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140440763835984"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms665032f6.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms665032f6.jpg" src="/pmc/articles/PMC4387075/bin/nihms665032f6.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140440763835984"><a target="object" rel="noopener" href="/pmc/articles/PMC4387075/figure/F6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F6"><div><a class="figpopup" href="/pmc/articles/PMC4387075/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6">Figure 6</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Quisqualate, DHPG, and ACPD are not labile when incubated overnight</strong><p>Cerebellar granule cells were maintained in K25 media for 6-7 days in vitro and then incubated overnight with agonists in K5 media. The following day, culture conditioned agonists in K5 media were used to stimulate PI hydrolysis in parallel cultures of cerebellar granule cells. Results with conditioned media (closed symbols) are compared with PI hydrolysis in response to agonists freshly prepared in CO2-saturated K5 media (open symbols). There was no change in efficacy or potency for (A) quisqualate, (B) DHPG, and (C) ACPD in stimulating PI hydrolysis after overnight incubation with cerebellar granule cells. Data are means from 3 independent experiments with error bars representing S.E.M.</p></div></div></div><p id="P19" class="p p-last">The EC<sub>50</sub> and E<sub>max</sub> values for the eight mGlu<sub>1</sub> receptor ligands tested in this study are presented in <a href="/pmc/articles/PMC4387075/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>. The rank order of potency for PI hydrolysis is quisqualate &#x0226b; glutamate &#x02248; aspartate &#x02248; CA &#x02248; DHPG &#x02248; HCA &#x02248; CSA &#x02248; ACPD; for increased cell viability in K5 conditions, the rank order of potency is CA &#x02248; CSA &#x02248; HCA &#x0003e; aspartate &#x02248; glutamate. While the sulfur-containing compounds (HCA, CA, CSA) have similar EC<sub>50</sub> values for both assays, glutamate and aspartate are both more potent in inducing PI hydrolysis. This difference in potency for glutamate and aspartate may be explained by uptake of these compounds via excitatory amino acid transporters (<a href="#R39" rid="R39" class=" bibr popnode">Velaz-Faircloth et al., 1996</a>) during the long incubation period required for cell viability experiments, resulting in a decreased effective agonist concentration and thus lower EC<sub>50</sub>. In support of this hypothesis, the apparent amount of glutamate in K5 media was reduced after overnight incubation with granule cell cultures (<a href="#SD2" rid="SD2" class=" supplementary-material">Supplemental Figure 1</a>). On the other hand, EC<sub>50</sub> values could not be calculated for quisqualate, DHPG, and ACPD as these compounds did not significantly increase viability of granule cells in K5 conditions. While quisqualate is extremely potent in stimulating PI hydrolysis, it has no efficacy for protection from K5 toxicity, even at concentrations greater than 200 times its EC<sub>50</sub> for PI hydrolysis. Similarly, neither DHPG nor ACPD caused a significant increase in granule cell viability in K5 conditions, but both stimulated PI hydrolysis. It is interesting to note that all the endogenous compounds tested stimulated both responses, whereas the exogenous compounds only stimulated PI hydrolysis.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Summary of E<sub>max</sub> and EC<sub>50</sub> values for two mGlu<sub>1</sub> receptor-mediated responses in cerebellar granule cells</strong><p>Data are summaries of those presented in <a href="/pmc/articles/PMC4387075/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>figure 3</span></a> (increased granule cell viability in K5 cultures), and <a href="/pmc/articles/PMC4387075/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>figure 4</span></a> (PI hydrolysis). For each agonist, efficacy is represented as a percentage of the efficacy of glutamate, the endogenous mGlu<sub>1</sub> receptor agonist. N.D. (not determined) is used when an agonist had no significant efficacy and thus EC<sub>50</sub> values could not be calculated. Values are calculated using data from at least 2 independent experiments performed in duplicate and are presented as mean +/- 95% confidence interval.</p></div><div class="xtable"><table frame="below" rules="groups" class="rendered small default_table"><thead><tr><th align="center" valign="bottom" rowspan="1" colspan="1"></th><th align="center" colspan="2" rowspan="1">Neuroprotection</th><th align="center" colspan="2" rowspan="1">PI hydrolysis</th></tr><tr><th align="center" rowspan="1" colspan="1">Agonist</th><th align="center" rowspan="1" colspan="1">E<sub>max</sub>, % glu</th><th align="center" rowspan="1" colspan="1">EC<sub>50</sub>, &#x003bc;M</th><th align="center" rowspan="1" colspan="1">E<sub>max</sub>, % glu</th><th align="center" rowspan="1" colspan="1">EC<sub>50</sub>, &#x003bc;M</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">Glutamate</td><td align="center" rowspan="1" colspan="1">100 &#x000b1; 9.9</td><td align="center" rowspan="1" colspan="1">76 (52 - 111)</td><td align="center" rowspan="1" colspan="1">100 &#x000b1; 2.6</td><td align="center" rowspan="1" colspan="1">12 (11 - 14)</td></tr><tr><td align="center" rowspan="1" colspan="1">Aspartate</td><td align="center" rowspan="1" colspan="1">101 &#x000b1; 8.7</td><td align="center" rowspan="1" colspan="1">51 (40 - 65)</td><td align="center" rowspan="1" colspan="1">103 &#x000b1; 7.8</td><td align="center" rowspan="1" colspan="1">19 (12 - 32)</td></tr><tr><td align="center" rowspan="1" colspan="1">Cysteic acid</td><td align="center" rowspan="1" colspan="1">94 &#x000b1; 7.3</td><td align="center" rowspan="1" colspan="1">23 (18 - 29)</td><td align="center" rowspan="1" colspan="1">87 &#x000b1; 4.2</td><td align="center" rowspan="1" colspan="1">22 (15 - 30)</td></tr><tr><td align="center" rowspan="1" colspan="1">Homocysteic acid</td><td align="center" rowspan="1" colspan="1">95 &#x000b1; 12</td><td align="center" rowspan="1" colspan="1">31 (14 - 69)</td><td align="center" rowspan="1" colspan="1">84 &#x000b1; 7.4</td><td align="center" rowspan="1" colspan="1">29 (14 - 58)</td></tr><tr><td align="center" rowspan="1" colspan="1">Cysteine sulfinic acid</td><td align="center" rowspan="1" colspan="1">99 &#x000b1; 7.5</td><td align="center" rowspan="1" colspan="1">28 (25 - 31)</td><td align="center" rowspan="1" colspan="1">82 &#x000b1; 10</td><td align="center" rowspan="1" colspan="1">29 (11 - 58)</td></tr><tr><td align="center" rowspan="1" colspan="1">Quisqualate</td><td align="center" rowspan="1" colspan="1">N.D.</td><td align="center" rowspan="1" colspan="1">N.D.</td><td align="center" rowspan="1" colspan="1">109 &#x000b1; 7.8</td><td align="center" rowspan="1" colspan="1">0.44 (0.13 - 1.5)</td></tr><tr><td align="center" rowspan="1" colspan="1">DHPG</td><td align="center" rowspan="1" colspan="1">N.D.</td><td align="center" rowspan="1" colspan="1">N.D.</td><td align="center" rowspan="1" colspan="1">69 &#x000b1; 3.7</td><td align="center" rowspan="1" colspan="1">23 (14 - 37)</td></tr><tr><td align="center" rowspan="1" colspan="1">ACPD</td><td align="center" rowspan="1" colspan="1">N.S.</td><td align="center" rowspan="1" colspan="1">N.D.</td><td align="center" rowspan="1" colspan="1">66 &#x000b1; 1.4</td><td align="center" rowspan="1" colspan="1">30 (28 - 32)</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140440761696752"><a target="object" rel="noopener" href="/pmc/articles/PMC4387075/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><p class="p p-first">N.D. = not detected</p><p class="p p-last">N.S. = not significant</p></div></div></div></div></div><div id="S14" class="tsec sec"><h2 class="head no_bottom_margin" id="S14title">4. Discussion</h2><p id="P20" class="p p-first">It is becoming increasingly apparent that GPCR signaling is more complex than the canonical activation of a G protein. An increasing number of GPCRs, including mGlu<sub>1</sub> receptors, are reported to couple to multiple G proteins and non-G protein transducers. mGlu<sub>1</sub> receptors originally were reported to increase phospholipase C activity (<a href="#R14" rid="R14" class=" bibr popnode">Houamed et al., 1991</a>; <a href="#R19" rid="R19" class=" bibr popnode">Masu et al., 1991</a>) by coupling with Gq/11 and/or with Gi/o (<a href="#R35" rid="R35" class=" bibr popnode">Selkirk et al., 2001</a>). In heterologous systems, mGlu<sub>1</sub> receptors also stimulate G protein-independent responses, including &#x003b2;-arrestin-dependent signaling (<a href="#R8" rid="R8" class=" bibr popnode">Emery et al., 2012</a>, <a href="#R9" rid="R9" class=" bibr popnode">2010</a>). However, while G protein signaling and PI hydrolysis has been confirmed in neurons, alternative signaling mediated by mGlu<sub>1</sub> receptors in native systems is not well described (<a href="#R10" rid="R10" class=" bibr popnode">Ferraguti et al., 2008</a>). In this study we characterize mGlu<sub>1</sub> receptor signaling using two methods and multiple ligands in the physiologically relevant model of cerebellar granule cells.</p><p id="P21">Stimulation of granule cells with glutamate increases PI hydrolysis and also protects granule cells from low potassium-induced toxicity. Both of these actions require mGlu<sub>1</sub> receptor activation, as both responses were blocked with mGlu<sub>1</sub> receptor antagonists but were unaffected by other glutamate receptor antagonists. In contrast to glutamate, some mGlu<sub>1</sub> receptor ligands (quisqualate, DHPG, and ACPD) stimulated PI hydrolysis, but were unable to protect granule cells from decreased viability after potassium removal. Thus these ligands are mGlu<sub>1</sub> receptor agonists that are completely biased towards PI hydrolysis. On the other hand glutamate, aspartate, CA, HCA, and CSA were balanced agonists with equal efficacies for both responses (<a href="/pmc/articles/PMC4387075/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Figure 7</span></a>). To our knowledge, this study is the first demonstration of bias agonism of a class C GPCR in a native system.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F7" co-legend-rid="lgnd_F7"><a href="/pmc/articles/PMC4387075/figure/F7/" target="figure" rid-figpopup="F7" rid-ob="ob-F7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140440761703712"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms665032f7.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms665032f7.jpg" src="/pmc/articles/PMC4387075/bin/nihms665032f7.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140440761703712"><a target="object" rel="noopener" href="/pmc/articles/PMC4387075/figure/F7/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F7"><div><a class="figpopup" href="/pmc/articles/PMC4387075/figure/F7/" target="figure" rid-figpopup="F7" rid-ob="ob-F7">Figure 7</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Biased agonism of mGlu<sub>1</sub> receptors in cerebellar granule cells</strong><p>Cartesian representation of relative efficacy for neuroprotection from K5 toxicity (y-axis) versus relative efficacy for PI hydrolysis (x-axis). Coordinates are from E<sub>max</sub> values in <a href="/pmc/articles/PMC4387075/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a> Error bars represent 95% confidence intervals.</p></div></div></div><p id="P22">Biased agonism may be explained by distinct coupling of mGlu<sub>1</sub> receptors with different transducers based on the bound ligand. This is supported by emerging modifications to receptor theory wherein a GPCR has numerous &#x0201c;active&#x0201d; states, with certain ligand-bound receptor confirmations favoring one transducer/pathway over another (<a href="#R31" rid="R31" class=" bibr popnode">Reiter et al., 2012</a>). In this case, a biased agonist is one that preferentially stabilizes specific receptor-transducer complexes, i.e. an agonist that has different molecular efficacies for different transducer systems (<a href="#R37" rid="R37" class=" bibr popnode">Strachan et al., 2014</a>). Additionally, the transducer itself plays a role in receptor conformation and resulting signal transduction. Thus, cell- and tissue-dependent changes in transducer availability can change the signaling profile of a receptor (<a href="#R21" rid="R21" class=" bibr popnode">Maudsley et al., 2005</a>). Therefore it is vital that receptor responses are measured in native systems using endogenous agonists, when possible, to fully assess the physiological function of a receptor.</p><p id="P23">It is interesting to note that the IC<sub>50</sub> values for both mGlu<sub>1</sub> receptor antagonists used in this study were substantially higher than previously published results (JNJ16259685: 19.8 &#x003bc;M in this study versus 1.7 nM (<a href="#R16" rid="R16" class=" bibr popnode">Lavreysen et al., 2004</a>). CPCCOEt: 123 &#x003bc;M in this study versus 9.9 &#x003bc;M (<a href="#R16" rid="R16" class=" bibr popnode">Lavreysen et al., 2004</a>; <a href="#R17" rid="R17" class=" bibr popnode">Litschig et al., 1999</a>)). It is important to emphasize that these previously reported IC<sub>50</sub> values were calculated based on antagonist ability to block agonist-induced PI hydrolysis, whereas the IC<sub>50</sub> values reported in this study were calculated based on antagonist inhibition of glutamatedependent neuroprotection. Additionally, in a model of glutamate-dependent cell growth of two mGlu<sub>1</sub> receptor-expressing human melanoma cell lines, the IC<sub>50</sub> for JNJ16259685 is approximately 100 &#x003bc;M, as measured by cell viability (<a href="#R12" rid="R12" class=" bibr popnode">Gelb et al., 2014</a>). Thus, it is possible that these mGlu<sub>1</sub> receptor noncompetitive antagonists may be more potent in inhibiting mGlu<sub>1</sub> receptor-mediated PI hydrolysis compared to mGlu<sub>1</sub> receptor-dependent increases in cell viability. Indeed, a natural progression of the receptor theory that explains biased agonism also suggests the propensity for biased antagonism. The multidimensionality of GPCR signaling suggests there are multiple receptor confirmations that promote varied signal transduction (i.e. multiple &#x0201c;active&#x0201d; confirmations); it therefore follows that there are multiple &#x0201c;inactive&#x0201d; confirmations with antagonist binding stabilizing one or more of these states. Just as an agonist can preferentially stabilize one &#x0201c;active&#x0201d; receptor confirmation (a biased agonist) it is logical that an antagonist could also have different affinities for certain &#x0201c;inactive&#x0201d; receptor confirmations, and indeed such biased antagonism is reported for other GPCRs (<a href="#R7" rid="R7" class=" bibr popnode">Dias et al., 2011</a>; <a href="#R15" rid="R15" class=" bibr popnode">Kenakin, 2014</a>; <a href="#R20" rid="R20" class=" bibr popnode">Mathiesen et al., 2005</a>). Thus, the higher IC<sub>50</sub> values for inhibition of glutamate-stimulated neuroprotection suggests that these mGlu<sub>1</sub> receptor antagonists may be biased towards inhibiting PI hydrolysis. This finding further emphasizes the importance of using multiple assays when characterizing receptor signaling and pharmacology.</p><p id="P24">In this study, we characterized native mGlu<sub>1</sub> receptors in cerebellar granule cells using a panel of ligands via two assays. The first, protection from K5 toxicity, was investigated because this is a common paradigm in cerebellar granule cells (<a href="#R4" rid="R4" class=" bibr popnode">Contestabile, 2002</a>) and because we previously reported glutamate could prevent this toxicity (<a href="#R28" rid="R28" class=" bibr popnode">Pshenichkin et al., 2008</a>). The second, PI hydrolysis, was investigated because it is one of the most commonly used measures of mGlu<sub>1</sub> receptor activation (<a href="#R10" rid="R10" class=" bibr popnode">Ferraguti et al., 2008</a>). It is well established that PI hydrolysis is a result of G protein activation, but less is known about the signal transduction responsible for mGlu<sub>1</sub> receptor-mediated protection from withdrawal of trophic support. From our studies it is obvious that mGlu<sub>1</sub> receptor stimulation of PI hydrolysis is not sufficient to protect from K5 toxicity as some ligands that stimulate PI hydrolysis are not protective. However, the elucidation of the neuroprotective molecular mechanism is complicated by a lack of unbiased mGlu<sub>1</sub> receptor-selective agonists. As quisqualate, DHPG, and ACPD are group I mGlu receptor preferring these ligands are commonly used to study mGlu<sub>1</sub> receptor signaling in neurons so as to reduce effects of other glutamate receptors. Thus, much of what is known about mGlu<sub>1</sub> receptor signaling in native systems is in response to these non-protective, PI hydrolysis-biased agonists (<a href="#R10" rid="R10" class=" bibr popnode">Ferraguti et al., 2008</a>) and may not be applicable to the signal transduction that underlies neuroprotection.</p><p id="P25">To study the molecular mechanism responsible for mGlu<sub>1</sub> receptor-mediated neuroprotection it would be most efficient to use agonists that are biased towards this response. In mGlu<sub>1</sub> receptor-expressing CHO cells, we previously reported two such mGlu<sub>1</sub> receptor ligands: glutaric acid and succinic acid. These agonists had no efficacy for PI hydrolysis but were able to protect mGlu<sub>1</sub> receptor-expressing CHO cells from serum starvation, and thus were biased towards protection. Both agonists exhibited low potency and efficacy (relative to glutamate) (<a href="#R8" rid="R8" class=" bibr popnode">Emery et al., 2012</a>), even though these experiments were performed in an overexpression system with significant receptor reserve (<a href="#R9" rid="R9" class=" bibr popnode">Emery et al., 2010</a>), implying that these agonists may require occupation of a large numbers of receptors to be efficacious. This may explain why results using these ligands in neurons were inconsistent and varied greatly between preparations of granule cells (data not shown). It is possible that the effects of these low-potency ligands are only apparent when mGlu<sub>1</sub> receptors are highly expressed, and that different preparations of granule cells express varying levels of mGlu<sub>1</sub> receptors. Regardless, to study the protective signaling of mGlu<sub>1</sub> receptors new, selective compounds with improved pharmacology need to be developed.</p><p id="P26">In the absence of agonists biased towards protection, the best ligands to study the neuroprotective mechanism underlying mGlu<sub>1</sub> receptor activation are balanced agonists such as glutamate. In this study, we show that extracellular glutamate, mGlu<sub>1</sub> receptor activation, and NMDA receptor activation are all required for the increase in granule cell viability mediated by NMDA treatment. This suggests that the protective actions of NMDA (and NMDA receptor activation) are due at least in part to release of glutamate and secondary activation of mGlu<sub>1</sub> receptors. Thus, studies on the effect of NMDA in K5 (<a href="#R4" rid="R4" class=" bibr popnode">Contestabile, 2002</a>) may provide a reasonable hypothesis for the signal transduction responsible for mGlu<sub>1</sub> receptor-mediated neuroprotection. For example, addition of NMDA to cerebellar granule cells cultured in K5 conditions increases Ras activity, resulting in phosphorylation of ERK and Akt (<a href="#R44" rid="R44" class=" bibr popnode">Xifr&#x000f3; et al., 2014</a>). Additional evidence comes from studies in melanoma cell lines, which secrete high concentrations of glutamate (<a href="#R25" rid="R25" class=" bibr popnode">Namkoong et al., 2007</a>). In melanoma cells, targeted downregulation of mGlu<sub>1</sub> receptors decreases ERK and AKT phosphorylation (<a href="#R41" rid="R41" class=" bibr popnode">Wangari-Talbot et al., 2012</a>), whereas overexpression of mGlu<sub>1</sub> receptors increases ERK and AKT phosphorylation (<a href="#R42" rid="R42" class=" bibr popnode">Wen et al., 2014</a>). Additionally, in transfected CHO cells, mGlu<sub>1</sub> receptor stimulation increases ERK phosphorylation and is required for protection from toxicity after serum starvation. This increase in ERK phosphorylation is mediated via a G protein-independent, &#x003b2;-arrestin-dependent pathway (<a href="#R9" rid="R9" class=" bibr popnode">Emery et al., 2010</a>) with a biased agonism profile similar to granule cells, namely that quisqualate and DHPG do not stimulate ERK phosphorylation or protection (<a href="#R8" rid="R8" class=" bibr popnode">Emery et al., 2012</a>). These studies suggest that the anti-apoptotic signaling of mGlu<sub>1</sub> receptors in neurons may involve stimulation of the MEK/ERK MAP kinase cascade and/or the PI3 kinase/Akt cascade via a PI hydrolysis-independent mechanism.</p><p id="P27" class="p p-last">As we understand more about the complexity of receptor activation, it becomes overwhelmingly apparent that measuring a single readout using a single ligand provides a limited glimpse into the complete signaling profile of a receptor. Relying on one ligand and/or readout restricts our understanding of the physiological role of a receptor and thus makes selective drug design more difficult. Understanding the signaling of mGlu<sub>1</sub> receptors in physiological systems is vital as these receptors may be involved in the pathophysiology of numerous diseases (<a href="#R26" rid="R26" class=" bibr popnode">Nicoletti et al., 2011</a>). Notably, loss of mGlu<sub>1</sub> receptor function may contribute to the pathology of spinocerebellar ataxias (<a href="#R13" rid="R13" class=" bibr popnode">Guergueltcheva et al., 2012</a>; <a href="#R22" rid="R22" class=" bibr popnode">Mitsumura et al., 2011</a>; <a href="#R32" rid="R32" class=" bibr popnode">Rossi et al., 2010</a>), and activation of mGlu<sub>1</sub> receptors using a positive allosteric modulator has shown therapeutic potential in ataxic mice (<a href="#R27" rid="R27" class=" bibr popnode">Notartomaso et al., 2013</a>). These findings highlight the importance of mGlu<sub>1</sub> receptors in cerebellar physiology and emphasize the need to fully understand the signal transduction mediated by mGlu<sub>1</sub> receptors in native systems. Additionally, a thorough understanding of biased agonism of mGlu<sub>1</sub> receptors may lead to the development of pathway-selective mGlu<sub>1</sub> receptor compounds. Such selective ligands would be valuable pharmacological tools for studying receptor function, and could provide a novel therapeutic approach for the treatment of diseases associated with mGlu<sub>1</sub> receptors.</p></div><div id="unreferenced-ft" class="tsec sec"><div class="unreferenced">​
                    <div class="boxed-text-box whole_rhythm hide-overflow" id="BX1"><div class="caption"><h3 id="caption-a.o.i.atitle">Highlights</h3></div><ul class="unordered" style="list-style-type:disc" id="L1"><li><div>Glutamate protects cerebellar granule cells from low potassium toxicity.</div></li><li><div>Neuroprotection is mediated by activation of metabotropic glutamate receptor 1.</div></li><li><div>Only some agonists of metabotropic glutamate receptor 1 are neuroprotective.</div></li><li><div>The biased agonists quisqualate, DHPG and ACPD have no efficacy for neuroprotection.</div></li></ul></div></div></div><div id="S15" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="S15title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD2"><!--caption a9--><strong>Supplemental Figure 1. Overnight incubation with granule cells reduces the concentration of extracellular glutamate: </strong><p id="P28">Increasing concentrations of glutamate were added to 7DIV cerebellar granule cells in K5 media and incubated at 37&#x000b0;C in 5% CO<sub>2</sub>. The following day this cultured conditioned media was removed and the apparent concentration of glutamate was assayed using the Amplex Red glutamic acid assay kit (Molecular Probes, Eugene, OR) and resulting fluorescence (proportional to glutamate concentration) was measured according to the manufacturer&#x02019;s instructions. Relative fluorescent units of culture conditioned glutamate (open symbols) are compared to the signal obtained from glutamate freshly diluted in K5 media (closed symbols). In the culture conditioned media, the signal relative to an EC<sub>50</sub> glutamate concentration (76 &#x003bc;M) is equivalent to the signal obtained by 19 &#x003bc;M freshly prepared glutamate, as indicated by the grey arrows. For each point, background fluorescence was corrected by subtracting values derived from controls lacking glutamate. Data are means from 2 experiments with error bars representing S.D.</p><div class="sup-box half_rhythm" id="d36e995"><a href="/pmc/articles/PMC4387075/bin/NIHMS665032-supplement-supplement_1.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(29K, pdf)</sup></div></div></div><div id="S16" class="tsec sec"><h2 class="head no_bottom_margin" id="S16title">Acknowledgments</h2><div class="sec"><p>This work was supported by The National Institutes of Health Grant NS37436 to JTW.</p></div></div><div id="GL" class="tsec sec"><h2 class="head no_bottom_margin" id="GLtitle">Abbreviations</h2><div class="bk-sec"><div><table class="default-table glossary"><tbody><tr><td id="G1">ACPD</td><td>1-Aminocyclopentane-1,3-dicarboxylic acid</td></tr><tr><td id="G2">MTT</td><td>3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium</td></tr><tr><td id="G3">DHPG</td><td>3,5-dihydroxyphenylglycine</td></tr><tr><td id="G4">CPCCOEt</td><td>7-(Hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester</td></tr><tr><td id="G5">CA</td><td>Cysteic acid</td></tr><tr><td id="G6">CSA</td><td>Cysteine sulfinic acid</td></tr><tr><td id="G7">GPCR</td><td>G protein-coupled receptor</td></tr><tr><td id="G8">HCA</td><td>Homocysteic acid</td></tr><tr><td id="G9">mGlu</td><td>Metabotropic glutamate</td></tr><tr><td id="G10">MTT</td><td>3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide</td></tr><tr><td id="G11">NMDA</td><td>N-methyl-D-aspartate</td></tr><tr><td id="G12">PI</td><td>Phosphoinositide</td></tr></tbody></table></div></div></div><div id="fn-group-a.n.b" class="tsec sec"><h2 class="head no_bottom_margin" id="fn-group-a.n.btitle">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN2"><p class="p p-first-last"><strong>Publisher's Disclaimer: </strong>This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.</p></p></div></div><div id="ref-list-a.n.c" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.n.ctitle">References</h2><div class="ref-list-sec sec" id="reference-list"><ul class="back-ref-list" style="list-style-type:decimal;"><li id="R1"><span class="element-citation">Bal&#x000e1;zs R, J&#x000f8;rgensen OS, Hack N. N-methyl-D-aspartate promotes the survival of cerebellar granule cells in culture. <span><span class="ref-journal">Neuroscience. </span>1988;<span class="ref-vol">27</span>:437–51.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/2905787" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;title=N-methyl-D-aspartate+promotes+the+survival+of+cerebellar+granule+cells+in+culture&amp;author=R+Bal&#x000e1;zs&amp;author=OS+J&#x000f8;rgensen&amp;author=N+Hack&amp;volume=27&amp;publication_year=1988&amp;pages=437-51&amp;pmid=2905787&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R2"><span class="element-citation">Caraci F, Battaglia G, Sortino MA, Spampinato S, Molinaro G, Copani A, Nicoletti F, Bruno V. Metabotropic glutamate receptors in neurodegeneration/neuroprotection: still a hot topic? <span><span class="ref-journal">Neurochem Int. </span>2012;<span class="ref-vol">61</span>:559–65. doi: 10.1016/j.neuint.2012.01.017.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22306345" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.neuint.2012.01.017" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurochem+Int&amp;title=Metabotropic+glutamate+receptors+in+neurodegeneration/neuroprotection:+still+a+hot+topic?&amp;author=F+Caraci&amp;author=G+Battaglia&amp;author=MA+Sortino&amp;author=S+Spampinato&amp;author=G+Molinaro&amp;volume=61&amp;publication_year=2012&amp;pages=559-65&amp;pmid=22306345&amp;doi=10.1016/j.neuint.2012.01.017&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R3"><span class="element-citation">Conn PJ, Pin JP. Pharmacology and functions of metabotropic glutamate receptors. <span><span class="ref-journal">Annu Rev Pharmacol Toxicol. </span>1997;<span class="ref-vol">37</span>:205–37. doi: 10.1146/annurev.pharmtox.37.1.205.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9131252" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1146%2Fannurev.pharmtox.37.1.205" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Pharmacol+Toxicol&amp;title=Pharmacology+and+functions+of+metabotropic+glutamate+receptors&amp;author=PJ+Conn&amp;author=JP+Pin&amp;volume=37&amp;publication_year=1997&amp;pages=205-37&amp;pmid=9131252&amp;doi=10.1146/annurev.pharmtox.37.1.205&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R4"><span class="element-citation">Contestabile A. Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro. <span><span class="ref-journal">Cerebellum. </span>2002;<span class="ref-vol">1</span>:41–55. doi: 10.1080/147342202753203087.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12879973" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1080%2F147342202753203087" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cerebellum&amp;title=Cerebellar+granule+cells+as+a+model+to+study+mechanisms+of+neuronal+apoptosis+or+survival+in+vivo+and+in+vitro&amp;author=A+Contestabile&amp;volume=1&amp;publication_year=2002&amp;pages=41-55&amp;pmid=12879973&amp;doi=10.1080/147342202753203087&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R5"><span class="element-citation">Copani A, Bruno VM, Barresi V, Battaglia G, Condorelli DF, Nicoletti F. Activation of metabotropic glutamate receptors prevents neuronal apoptosis in culture. <span><span class="ref-journal">J Neurochem. </span>1995;<span class="ref-vol">64</span>:101–8. doi: 10.1046/j.1471-4159.1995.64010101.x.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7798903" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1046%2Fj.1471-4159.1995.64010101.x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;title=Activation+of+metabotropic+glutamate+receptors+prevents+neuronal+apoptosis+in+culture&amp;author=A+Copani&amp;author=VM+Bruno&amp;author=V+Barresi&amp;author=G+Battaglia&amp;author=DF+Condorelli&amp;volume=64&amp;publication_year=1995&amp;pages=101-8&amp;pmid=7798903&amp;doi=10.1046/j.1471-4159.1995.64010101.x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R6"><span class="element-citation">DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK. &#x003b2;-Arrestins and Cell Signaling. <span><span class="ref-journal">Annu Rev Physiol. </span>2007;<span class="ref-vol">69</span>:483–510. doi: 10.1146/annurev.physiol.69.022405.154749.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17305471" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1146%2Fannurev.physiol.69.022405.154749" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Physiol&amp;title=&#x003b2;-Arrestins+and+Cell+Signaling&amp;author=SM+DeWire&amp;author=S+Ahn&amp;author=RJ+Lefkowitz&amp;author=SK+Shenoy&amp;volume=69&amp;publication_year=2007&amp;pages=483-510&amp;pmid=17305471&amp;doi=10.1146/annurev.physiol.69.022405.154749&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R7"><span class="element-citation">Dias Ja, Bonnet B, Weaver Ba, Watts J, Kluetzman K, Thomas RM, Poli S, Mutel V, Campo B. A negative allosteric modulator demonstrates biased antagonism of the follicle stimulating hormone receptor. <span><span class="ref-journal">Mol Cell Endocrinol. </span>2011;<span class="ref-vol">333</span>:143–50. doi: 10.1016/j.mce.2010.12.023.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4491433/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21184806" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.mce.2010.12.023" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Endocrinol&amp;title=A+negative+allosteric+modulator+demonstrates+biased+antagonism+of+the+follicle+stimulating+hormone+receptor&amp;author=Ja+Dias&amp;author=B+Bonnet&amp;author=Ba+Weaver&amp;author=J+Watts&amp;author=K+Kluetzman&amp;volume=333&amp;publication_year=2011&amp;pages=143-50&amp;pmid=21184806&amp;doi=10.1016/j.mce.2010.12.023&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R8"><span class="element-citation">Emery AC, DiRaddo JO, Miller E, Hathaway Ha, Pshenichkin S, Takoudjou GR, Grajkowska E, Yasuda RP, Wolfe BB, Wroblewski JT. Ligand bias at metabotropic glutamate 1a receptors: molecular determinants that distinguish &#x003b2;-arrestin-mediated from G protein-mediated signaling. <span><span class="ref-journal">Mol Pharmacol. </span>2012;<span class="ref-vol">82</span>:291–301. doi: 10.1124/mol.112.078444.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3400838/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22584219" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1124%2Fmol.112.078444" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;title=Ligand+bias+at+metabotropic+glutamate+1a+receptors:+molecular+determinants+that+distinguish+&#x003b2;-arrestin-mediated+from+G+protein-mediated+signaling&amp;author=AC+Emery&amp;author=JO+DiRaddo&amp;author=E+Miller&amp;author=Ha+Hathaway&amp;author=S+Pshenichkin&amp;volume=82&amp;publication_year=2012&amp;pages=291-301&amp;pmid=22584219&amp;doi=10.1124/mol.112.078444&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R9"><span class="element-citation">Emery AC, Pshenichkin S, Takoudjou GR, Grajkowska E, Wolfe BB, Wroblewski JT. The protective signaling of metabotropic glutamate receptor 1 Is mediated by sustained, beta-arrestin-1-dependent ERK phosphorylation. <span><span class="ref-journal">J Biol Chem. </span>2010;<span class="ref-vol">285</span>:26041–8. doi: 10.1074/jbc.M110.139899.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2924003/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20566651" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1074%2Fjbc.M110.139899" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=The+protective+signaling+of+metabotropic+glutamate+receptor+1+Is+mediated+by+sustained,+beta-arrestin-1-dependent+ERK+phosphorylation&amp;author=AC+Emery&amp;author=S+Pshenichkin&amp;author=GR+Takoudjou&amp;author=E+Grajkowska&amp;author=BB+Wolfe&amp;volume=285&amp;publication_year=2010&amp;pages=26041-8&amp;pmid=20566651&amp;doi=10.1074/jbc.M110.139899&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R10"><span class="element-citation">Ferraguti F, Crepaldi L, Nicoletti F. Metabotropic Glutamate 1 Receptor: Current Concepts and Perspectives. <span><span class="ref-journal">Pharmacol Rev. </span>2008;<span class="ref-vol">60</span>:536–581. doi: 10.1124/pr.108.000166.536.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19112153" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1124%2Fpr.108.000166.536" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Rev&amp;title=Metabotropic+Glutamate+1+Receptor:+Current+Concepts+and+Perspectives&amp;author=F+Ferraguti&amp;author=L+Crepaldi&amp;author=F+Nicoletti&amp;volume=60&amp;publication_year=2008&amp;pages=536-581&amp;pmid=19112153&amp;doi=10.1124/pr.108.000166.536&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R11"><span class="element-citation">Gallo V, Kingsbury A, Bal&#x000e1;zs R, J&#x000f8;rgensen OS. The role of depolarization in the survival and differentiation of cerebellar granule cells in culture. <span><span class="ref-journal">J Neurosci. </span>1987;<span class="ref-vol">7</span>:2203–13.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6568938/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/2886565" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;title=The+role+of+depolarization+in+the+survival+and+differentiation+of+cerebellar+granule+cells+in+culture&amp;author=V+Gallo&amp;author=A+Kingsbury&amp;author=R+Bal&#x000e1;zs&amp;author=OS+J&#x000f8;rgensen&amp;volume=7&amp;publication_year=1987&amp;pages=2203-13&amp;pmid=2886565&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R12"><span class="element-citation">Gelb T, Pshenichkin S, Rodriguez OC, Hathaway Ha, Grajkowska E, DiRaddo JO, Wroblewska B, Yasuda RP, Albanese C, Wolfe BB, Wroblewski JT. Metabotropic glutamate receptor 1 acts as a dependence receptor creating a requirement for glutamate to sustain the viability and growth of human melanomas. <span><span class="ref-journal">Oncogene. </span>2014:1–10. doi: 10.1038/onc.2014.231.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5853109/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25065592" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fonc.2014.231" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Metabotropic+glutamate+receptor+1+acts+as+a+dependence+receptor+creating+a+requirement+for+glutamate+to+sustain+the+viability+and+growth+of+human+melanomas&amp;author=T+Gelb&amp;author=S+Pshenichkin&amp;author=OC+Rodriguez&amp;author=Ha+Hathaway&amp;author=E+Grajkowska&amp;publication_year=2014&amp;pages=1-10&amp;doi=10.1038/onc.2014.231&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R13"><span class="element-citation">Guergueltcheva V, Azmanov DN, Angelicheva D, Smith KR, Chamova T, Florez L, Bynevelt M, Nguyen T, Cherninkova S, Bojinova V, Kaprelyan A, Angelova L, Morar B, Chandler D, Kaneva R, Bahlo M, Tournev I, Kalaydjieva L. Autosomal-Recessive Congenital Cerebellar Ataxia Is Caused by Mutations in Metabotropic Glutamate Receptor 1. <span><span class="ref-journal">Am J Hum Genet. </span>2012:1–12. doi: 10.1016/j.ajhg.2012.07.019.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3511982/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22901947" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.ajhg.2012.07.019" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=Autosomal-Recessive+Congenital+Cerebellar+Ataxia+Is+Caused+by+Mutations+in+Metabotropic+Glutamate+Receptor+1&amp;author=V+Guergueltcheva&amp;author=DN+Azmanov&amp;author=D+Angelicheva&amp;author=KR+Smith&amp;author=T+Chamova&amp;publication_year=2012&amp;pages=1-12&amp;doi=10.1016/j.ajhg.2012.07.019&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R14"><span class="element-citation">Houamed KM, Kuijper JL, Gilbert TL, Haldeman BA, O&#x02019;Hara PJ, Mulvihill ER, Almers W, Hagen FS. Cloning, expression, and gene structure of a G protein-coupled glutamate receptor from rat brain. <span><span class="ref-journal">Science. </span>1991;<span class="ref-vol">252</span>:1318–21. doi: 10.1126/science.1656524.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1656524" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1126%2Fscience.1656524" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Cloning,+expression,+and+gene+structure+of+a+G+protein-coupled+glutamate+receptor+from+rat+brain&amp;author=KM+Houamed&amp;author=JL+Kuijper&amp;author=TL+Gilbert&amp;author=BA+Haldeman&amp;author=PJ+O&#x02019;Hara&amp;volume=252&amp;publication_year=1991&amp;pages=1318-21&amp;pmid=1656524&amp;doi=10.1126/science.1656524&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R15"><span class="element-citation">Kenakin T. What is pharmacological &#x0201c;affinity&#x0201d;? Relevance to biased agonism and antagonism. <span><span class="ref-journal">Trends Pharmacol Sci. </span>2014;<span class="ref-vol">35</span>:434–41. doi: 10.1016/j.tips.2014.06.003.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25042457" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.tips.2014.06.003" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Pharmacol+Sci&amp;title=What+is+pharmacological+&#x0201c;affinity&#x0201d;?+Relevance+to+biased+agonism+and+antagonism&amp;author=T+Kenakin&amp;volume=35&amp;publication_year=2014&amp;pages=434-41&amp;pmid=25042457&amp;doi=10.1016/j.tips.2014.06.003&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R16"><span class="element-citation">Lavreysen H, Wouters R, Bischoff F, N&#x000f3;brega Pereira S, Langlois X, Blokland S, Somers M, Dillen L, Lesage ASJ. JNJ16259685, a highly potent, selective and systemically active mGlu1 receptor antagonist. <span><span class="ref-journal">Neuropharmacology. </span>2004;<span class="ref-vol">47</span>:961–72. doi: 10.1016/j.neuropharm.2004.08.007.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15555631" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.neuropharm.2004.08.007" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=JNJ16259685,+a+highly+potent,+selective+and+systemically+active+mGlu1+receptor+antagonist&amp;author=H+Lavreysen&amp;author=R+Wouters&amp;author=F+Bischoff&amp;author=S+N&#x000f3;brega+Pereira&amp;author=X+Langlois&amp;volume=47&amp;publication_year=2004&amp;pages=961-72&amp;pmid=15555631&amp;doi=10.1016/j.neuropharm.2004.08.007&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R17"><span class="element-citation">Litschig S, Gasparini F, Rueegg D, Stoehr N, Flor PJ, Vranesic I, Pr&#x000e9;zeau L, Pin JP, Thomsen C, Kuhn R. CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding. <span><span class="ref-journal">Mol Pharmacol. </span>1999;<span class="ref-vol">55</span>:453–61.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10051528" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;title=CPCCOEt,+a+noncompetitive+metabotropic+glutamate+receptor+1+antagonist,+inhibits+receptor+signaling+without+affecting+glutamate+binding&amp;author=S+Litschig&amp;author=F+Gasparini&amp;author=D+Rueegg&amp;author=N+Stoehr&amp;author=PJ+Flor&amp;volume=55&amp;publication_year=1999&amp;pages=453-61&amp;pmid=10051528&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R18"><span class="element-citation">Luttrell LM, Gesty-Palmer D. Beyond desensitization: physiological relevance of arrestin-dependent signaling. <span><span class="ref-journal">Pharmacol Rev. </span>2010;<span class="ref-vol">62</span>:305–30. doi: 10.1124/pr.109.002436.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2879915/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20427692" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1124%2Fpr.109.002436" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Rev&amp;title=Beyond+desensitization:+physiological+relevance+of+arrestin-dependent+signaling&amp;author=LM+Luttrell&amp;author=D+Gesty-Palmer&amp;volume=62&amp;publication_year=2010&amp;pages=305-30&amp;pmid=20427692&amp;doi=10.1124/pr.109.002436&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R19"><span class="element-citation">Masu M, Tanabe Y, Tsuchida K, Shigemoto R, Nakanishi S. Sequence and expression of a metabotropic glutamate receptor. <span><span class="ref-journal">Nature. </span>1991;<span class="ref-vol">349</span>:760–5. doi: 10.1038/349760a0.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1847995" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2F349760a0" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Sequence+and+expression+of+a+metabotropic+glutamate+receptor&amp;author=M+Masu&amp;author=Y+Tanabe&amp;author=K+Tsuchida&amp;author=R+Shigemoto&amp;author=S+Nakanishi&amp;volume=349&amp;publication_year=1991&amp;pages=760-5&amp;pmid=1847995&amp;doi=10.1038/349760a0&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R20"><span class="element-citation">Mathiesen JM, Ulven T, Martini L, Gerlach LO, Heinemann A. Identification of Indole Derivatives Exclusively Interfering with a G Protein-Independent Signaling Pathway of the Prostaglandin D2 Receptor CRTH2. <span>2005;<span class="ref-vol">68</span>:393–402. doi: 10.1124/mol.104.010520.response.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15870392" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1124%2Fmol.104.010520.response" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar?q=Mathiesen+JM+Ulven+T+Martini+L+Gerlach+LO+Heinemann+A+2005+Identification+of+Indole+Derivatives+Exclusively+Interfering+with+a+G+Protein-Independent+Signaling+Pathway+of+the+Prostaglandin+D2+Receptor+CRTH2+68+393+402+10.1124/mol.104.010520.response+" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R21"><span class="element-citation">Maudsley S, Martin B, Luttrell LM. The origins of diversity and specificity in g protein-coupled receptor signaling. <span><span class="ref-journal">J Pharmacol Exp Ther. </span>2005;<span class="ref-vol">314</span>:485–94. doi: 10.1124/jpet.105.083121.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2656918/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15805429" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1124%2Fjpet.105.083121" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;title=The+origins+of+diversity+and+specificity+in+g+protein-coupled+receptor+signaling&amp;author=S+Maudsley&amp;author=B+Martin&amp;author=LM+Luttrell&amp;volume=314&amp;publication_year=2005&amp;pages=485-94&amp;pmid=15805429&amp;doi=10.1124/jpet.105.083121&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R22"><span class="element-citation">Mitsumura K, Hosoi N, Furuya N, Hirai H. Disruption of metabotropic glutamate receptor signalling is a major defect at cerebellar parallel fibre-Purkinje cell synapses in staggerer mutant mice. <span><span class="ref-journal">J Physiol. </span>2011;<span class="ref-vol">589</span>:3191–209. doi: 10.1113/jphysiol.2011.207563.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3145934/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21558162" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1113%2Fjphysiol.2011.207563" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Physiol&amp;title=Disruption+of+metabotropic+glutamate+receptor+signalling+is+a+major+defect+at+cerebellar+parallel+fibre-Purkinje+cell+synapses+in+staggerer+mutant+mice&amp;author=K+Mitsumura&amp;author=N+Hosoi&amp;author=N+Furuya&amp;author=H+Hirai&amp;volume=589&amp;publication_year=2011&amp;pages=3191-209&amp;pmid=21558162&amp;doi=10.1113/jphysiol.2011.207563&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R23"><span class="element-citation">Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. <span><span class="ref-journal">J Immunol Methods. </span>1983;<span class="ref-vol">65</span>:55–63. doi: 10.1016/0022-1759(83)90303-4.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/6606682" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2F0022-1759(83)90303-4" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol+Methods&amp;title=Rapid+colorimetric+assay+for+cellular+growth+and+survival:+application+to+proliferation+and+cytotoxicity+assays&amp;author=T+Mosmann&amp;volume=65&amp;publication_year=1983&amp;pages=55-63&amp;pmid=6606682&amp;doi=10.1016/0022-1759(83)90303-4&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R24"><span class="element-citation">Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. <span><span class="ref-journal">Science. </span>1992;<span class="ref-vol">258</span>:597–603. doi: 10.1126/science.1329206.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1329206" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1126%2Fscience.1329206" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Molecular+diversity+of+glutamate+receptors+and+implications+for+brain+function&amp;author=S+Nakanishi&amp;volume=258&amp;publication_year=1992&amp;pages=597-603&amp;pmid=1329206&amp;doi=10.1126/science.1329206&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R25"><span class="element-citation">Namkoong J, Shin S-S, Lee HJ, Mar&#x000ed;n YE, Wall Ba, Goydos JS, Chen S. Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma. <span><span class="ref-journal">Cancer Res. </span>2007;<span class="ref-vol">67</span>:2298–305. doi: 10.1158/0008-5472.CAN-06-3665.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17332361" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F0008-5472.CAN-06-3665" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Metabotropic+glutamate+receptor+1+and+glutamate+signaling+in+human+melanoma&amp;author=J+Namkoong&amp;author=S-S+Shin&amp;author=HJ+Lee&amp;author=YE+Mar&#x000ed;n&amp;author=Ba+Wall&amp;volume=67&amp;publication_year=2007&amp;pages=2298-305&amp;pmid=17332361&amp;doi=10.1158/0008-5472.CAN-06-3665&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R26"><span class="element-citation">Nicoletti F, Bockaert J, Collingridge GL, Conn PJ, Ferraguti F, Schoepp DD, Wroblewski JT, Pin JP. Metabotropic glutamate receptors: from the workbench to the bedside. <span><span class="ref-journal">Neuropharmacology. </span>2011;<span class="ref-vol">60</span>:1017–41. doi: 10.1016/j.neuropharm.2010.10.022.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3787883/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21036182" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.neuropharm.2010.10.022" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=Metabotropic+glutamate+receptors:+from+the+workbench+to+the+bedside&amp;author=F+Nicoletti&amp;author=J+Bockaert&amp;author=GL+Collingridge&amp;author=PJ+Conn&amp;author=F+Ferraguti&amp;volume=60&amp;publication_year=2011&amp;pages=1017-41&amp;pmid=21036182&amp;doi=10.1016/j.neuropharm.2010.10.022&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R27"><span class="element-citation">Notartomaso S, Zappulla C, Biagioni F, Cannella M, Bucci D, Mascio G, Scarselli P, Fazio F, Weisz F, Lionetto L, Simmaco M, Gradini R, Battaglia G, Signore M, Puliti A, Nicoletti F. Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1. <span><span class="ref-journal">Mol Brain. </span>2013;<span class="ref-vol">6</span>:48. doi: 10.1186/1756-6606-6-48.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4225515/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24252411" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1186%2F1756-6606-6-48" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Brain&amp;title=Pharmacological+enhancement+of+mGlu1+metabotropic+glutamate+receptors+causes+a+prolonged+symptomatic+benefit+in+a+mouse+model+of+spinocerebellar+ataxia+type+1&amp;author=S+Notartomaso&amp;author=C+Zappulla&amp;author=F+Biagioni&amp;author=M+Cannella&amp;author=D+Bucci&amp;volume=6&amp;publication_year=2013&amp;pages=48&amp;pmid=24252411&amp;doi=10.1186/1756-6606-6-48&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R28"><span class="element-citation">Pshenichkin S, Doli&#x00144;ska M, Klauzi&#x00144;ska M, Luchenko V, Grajkowska E, Wroblewski JT. Dual neurotoxic and neuroprotective role of metabotropic glutamate receptor 1 in conditions of trophic deprivation - possible role as a dependence receptor. <span><span class="ref-journal">Neuropharmacology. </span>2008;<span class="ref-vol">55</span>:500–8. doi: 10.1016/j.neuropharm.2008.06.039.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2606294/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18619982" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.neuropharm.2008.06.039" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=Dual+neurotoxic+and+neuroprotective+role+of+metabotropic+glutamate+receptor+1+in+conditions+of+trophic+deprivation+-+possible+role+as+a+dependence+receptor&amp;author=S+Pshenichkin&amp;author=M+Doli&#x00144;ska&amp;author=M+Klauzi&#x00144;ska&amp;author=V+Luchenko&amp;author=E+Grajkowska&amp;volume=55&amp;publication_year=2008&amp;pages=500-8&amp;pmid=18619982&amp;doi=10.1016/j.neuropharm.2008.06.039&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R29"><span class="element-citation">Rajagopal S, Ahn S, Rominger DH, Gowen-MacDonald W, Lam CM, Dewire SM, Violin JD, Lefkowitz RJ. Quantifying ligand bias at seven-transmembrane receptors. <span><span class="ref-journal">Mol Pharmacol. </span>2011;<span class="ref-vol">80</span>:367–77. doi: 10.1124/mol.111.072801.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3164332/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21610196" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1124%2Fmol.111.072801" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;title=Quantifying+ligand+bias+at+seven-transmembrane+receptors&amp;author=S+Rajagopal&amp;author=S+Ahn&amp;author=DH+Rominger&amp;author=W+Gowen-MacDonald&amp;author=CM+Lam&amp;volume=80&amp;publication_year=2011&amp;pages=367-77&amp;pmid=21610196&amp;doi=10.1124/mol.111.072801&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R30"><span class="element-citation">Rajagopal S, Rajagopal K, Lefkowitz RJ. Teaching old receptors new tricks: biasing seven-transmembrane receptors. <span><span class="ref-journal">Nat Rev Drug Discov. </span>2010;<span class="ref-vol">9</span>:373–86. doi: 10.1038/nrd3024.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2902265/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20431569" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fnrd3024" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Drug+Discov&amp;title=Teaching+old+receptors+new+tricks:+biasing+seven-transmembrane+receptors&amp;author=S+Rajagopal&amp;author=K+Rajagopal&amp;author=RJ+Lefkowitz&amp;volume=9&amp;publication_year=2010&amp;pages=373-86&amp;pmid=20431569&amp;doi=10.1038/nrd3024&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R31"><span class="element-citation">Reiter E, Ahn S, Shukla AK, Lefkowitz RJ. Molecular mechanism of &#x003b2;-arrestin-biased agonism at seven-transmembrane receptors. <span><span class="ref-journal">Annu Rev Pharmacol Toxicol. </span>2012;<span class="ref-vol">52</span>:179–97. doi: 10.1146/annurev.pharmtox.010909.105800.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3628752/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21942629" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1146%2Fannurev.pharmtox.010909.105800" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Pharmacol+Toxicol&amp;title=Molecular+mechanism+of+&#x003b2;-arrestin-biased+agonism+at+seven-transmembrane+receptors&amp;author=E+Reiter&amp;author=S+Ahn&amp;author=AK+Shukla&amp;author=RJ+Lefkowitz&amp;volume=52&amp;publication_year=2012&amp;pages=179-97&amp;pmid=21942629&amp;doi=10.1146/annurev.pharmtox.010909.105800&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R32"><span class="element-citation">Rossi PIA, Vaccari CM, Terracciano A, Doria-Lamba L, Facchinetti S, Priolo M, Ayuso C, De Jorge L, Gimelli S, Santorelli FM, Ravazzolo R, Puliti A. The metabotropic glutamate receptor 1, GRM1: evaluation as a candidate gene for inherited forms of cerebellar ataxia. <span><span class="ref-journal">J Neurol. </span>2010;<span class="ref-vol">257</span>:598–602. doi: 10.1007/s00415-009-5380-3.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19924463" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs00415-009-5380-3" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurol&amp;title=The+metabotropic+glutamate+receptor+1,+GRM1:+evaluation+as+a+candidate+gene+for+inherited+forms+of+cerebellar+ataxia&amp;author=PIA+Rossi&amp;author=CM+Vaccari&amp;author=A+Terracciano&amp;author=L+Doria-Lamba&amp;author=S+Facchinetti&amp;volume=257&amp;publication_year=2010&amp;pages=598-602&amp;pmid=19924463&amp;doi=10.1007/s00415-009-5380-3&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R33"><span class="element-citation">Santi MR, Ikonomovic S, Wroblewski JT, Grayson DR. Temporal and depolarization-induced changes in the absolute amounts of mRNAs encoding metabotropic glutamate receptors in cerebellar granule neurons in vitro. <span><span class="ref-journal">J Neurochem. </span>1994;<span class="ref-vol">63</span>:1207–17. doi: 10.1046/j.1471-4159.1994.63041207.x.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7931274" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1046%2Fj.1471-4159.1994.63041207.x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;title=Temporal+and+depolarization-induced+changes+in+the+absolute+amounts+of+mRNAs+encoding+metabotropic+glutamate+receptors+in+cerebellar+granule+neurons+in+vitro&amp;author=MR+Santi&amp;author=S+Ikonomovic&amp;author=JT+Wroblewski&amp;author=DR+Grayson&amp;volume=63&amp;publication_year=1994&amp;pages=1207-17&amp;pmid=7931274&amp;doi=10.1046/j.1471-4159.1994.63041207.x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R34"><span class="element-citation">Schoepp DD, Goldsworthy J, Johnson BG, Salhoff CR, Baker SR. 3,5-dihydroxyphenylglycine is a highly selective agonist for phosphoinositide-linked metabotropic glutamate receptors in the rat hippocampus. <span><span class="ref-journal">J Neurochem. </span>1994;<span class="ref-vol">63</span>:769–72. doi: 10.1046/j.1471-4159.1994.63020769.x.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8035201" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1046%2Fj.1471-4159.1994.63020769.x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;title=3,5-dihydroxyphenylglycine+is+a+highly+selective+agonist+for+phosphoinositide-linked+metabotropic+glutamate+receptors+in+the+rat+hippocampus&amp;author=DD+Schoepp&amp;author=J+Goldsworthy&amp;author=BG+Johnson&amp;author=CR+Salhoff&amp;author=SR+Baker&amp;volume=63&amp;publication_year=1994&amp;pages=769-72&amp;pmid=8035201&amp;doi=10.1046/j.1471-4159.1994.63020769.x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R35"><span class="element-citation">Selkirk JV, Price GW, Nahorski SR, Challiss RA. Cell type-specific differences in the coupling of recombinant mGlu1alpha receptors to endogenous G protein sub-populations. <span><span class="ref-journal">Neuropharmacology. </span>2001;<span class="ref-vol">40</span>:645–56. doi: 10.1016/S0028-3908(00)00208-2.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11311892" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FS0028-3908(00)00208-2" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=Cell+type-specific+differences+in+the+coupling+of+recombinant+mGlu1alpha+receptors+to+endogenous+G+protein+sub-populations&amp;author=JV+Selkirk&amp;author=GW+Price&amp;author=SR+Nahorski&amp;author=RA+Challiss&amp;volume=40&amp;publication_year=2001&amp;pages=645-56&amp;pmid=11311892&amp;doi=10.1016/S0028-3908(00)00208-2&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R36"><span class="element-citation">Shi Q, Savage JE, Hufeisen SJ, Rauser L, Grajkowska E, Ernsberger P, Wroblewski JT, Nadeau JH, Roth BL. L-homocysteine sulfinic acid and other acidic homocysteine derivatives are potent and selective metabotropic glutamate receptor agonists. <span><span class="ref-journal">J Pharmacol Exp Ther. </span>2003;<span class="ref-vol">305</span>:131–42. doi: 10.1124/jpet.102.047092.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12649361" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1124%2Fjpet.102.047092" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;title=L-homocysteine+sulfinic+acid+and+other+acidic+homocysteine+derivatives+are+potent+and+selective+metabotropic+glutamate+receptor+agonists&amp;author=Q+Shi&amp;author=JE+Savage&amp;author=SJ+Hufeisen&amp;author=L+Rauser&amp;author=E+Grajkowska&amp;volume=305&amp;publication_year=2003&amp;pages=131-42&amp;pmid=12649361&amp;doi=10.1124/jpet.102.047092&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R37"><span class="element-citation">Strachan RT, Sun J, Rominger DH, Violin JD, Ahn S, Rojas Bie Thomsen A, Zhu X, Kleist A, Costa T, Lefkowitz RJ. Divergent transducer-specific molecular efficacies generate biased agonism at a G protein-coupled receptor (GPCR) <span><span class="ref-journal">J Biol Chem. </span>2014;<span class="ref-vol">289</span>:14211–24. doi: 10.1074/jbc.M114.548131.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4022887/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24668815" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1074%2Fjbc.M114.548131" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Divergent+transducer-specific+molecular+efficacies+generate+biased+agonism+at+a+G+protein-coupled+receptor+(GPCR)&amp;author=RT+Strachan&amp;author=J+Sun&amp;author=DH+Rominger&amp;author=JD+Violin&amp;author=S+Ahn&amp;volume=289&amp;publication_year=2014&amp;pages=14211-24&amp;pmid=24668815&amp;doi=10.1074/jbc.M114.548131&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R38"><span class="element-citation">Toms NJ, Jane DE, Tse HW, Roberts PJ. Characterization of metabotropic glutamate receptor-stimulated phosphoinositide hydrolysis in rat cultured cerebellar granule cells. <span><span class="ref-journal">Br J Pharmacol. </span>1995;<span class="ref-vol">116</span>:2824–7. doi: 10.1111/j.1476-5381.1995.tb15932.x.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1909208/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8680712" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fj.1476-5381.1995.tb15932.x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;title=Characterization+of+metabotropic+glutamate+receptor-stimulated+phosphoinositide+hydrolysis+in+rat+cultured+cerebellar+granule+cells&amp;author=NJ+Toms&amp;author=DE+Jane&amp;author=HW+Tse&amp;author=PJ+Roberts&amp;volume=116&amp;publication_year=1995&amp;pages=2824-7&amp;pmid=8680712&amp;doi=10.1111/j.1476-5381.1995.tb15932.x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R39"><span class="element-citation">Velaz-Faircloth M, McGraw TS, Alandro MS, Fremeau RT, Kilberg MS, Anderson KJ. Characterization and distribution of the neuronal glutamate transporter EAAC1 in rat brain. <span><span class="ref-journal">Am J Physiol. </span>1996;<span class="ref-vol">270</span>:C67–75.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8772431" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol&amp;title=Characterization+and+distribution+of+the+neuronal+glutamate+transporter+EAAC1+in+rat+brain&amp;author=M+Velaz-Faircloth&amp;author=TS+McGraw&amp;author=MS+Alandro&amp;author=RT+Fremeau&amp;author=MS+Kilberg&amp;volume=270&amp;publication_year=1996&amp;pages=C67-75&amp;pmid=8772431&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R40"><span class="element-citation">Violin JD, Crombie AL, Soergel DG, Lark MW. Biased ligands at G-protein-coupled receptors: promise and progress. <span><span class="ref-journal">Trends Pharmacol Sci. </span>2014;<span class="ref-vol">35</span>:308–16. doi: 10.1016/j.tips.2014.04.007.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24878326" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.tips.2014.04.007" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Pharmacol+Sci&amp;title=Biased+ligands+at+G-protein-coupled+receptors:+promise+and+progress&amp;author=JD+Violin&amp;author=AL+Crombie&amp;author=DG+Soergel&amp;author=MW+Lark&amp;volume=35&amp;publication_year=2014&amp;pages=308-16&amp;pmid=24878326&amp;doi=10.1016/j.tips.2014.04.007&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R41"><span class="element-citation">Wangari-Talbot J, Wall Ba, Goydos JS, Chen S. Functional effects of GRM1 suppression in human melanoma cells. <span><span class="ref-journal">Mol Cancer Res. </span>2012;<span class="ref-vol">10</span>:1440–50. doi: 10.1158/1541-7786.MCR-12-0158.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3501593/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22798429" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F1541-7786.MCR-12-0158" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cancer+Res&amp;title=Functional+effects+of+GRM1+suppression+in+human+melanoma+cells&amp;author=J+Wangari-Talbot&amp;author=Ba+Wall&amp;author=JS+Goydos&amp;author=S+Chen&amp;volume=10&amp;publication_year=2012&amp;pages=1440-50&amp;pmid=22798429&amp;doi=10.1158/1541-7786.MCR-12-0158&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R42"><span class="element-citation">Wen Y, Li J, Koo J, Shin S-S, Lin Y, Jeong B-S, Mehnert JM, Chen S, Cohen-Sola Ka, Goydos JS. Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression. <span><span class="ref-journal">Cancer Res. </span>2014;<span class="ref-vol">74</span>:2499–509. doi: 10.1158/0008-5472.CAN-13-1531.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4008638/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24491800" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F0008-5472.CAN-13-1531" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Activation+of+the+glutamate+receptor+GRM1+enhances+angiogenic+signaling+to+drive+melanoma+progression&amp;author=Y+Wen&amp;author=J+Li&amp;author=J+Koo&amp;author=S-S+Shin&amp;author=Y+Lin&amp;volume=74&amp;publication_year=2014&amp;pages=2499-509&amp;pmid=24491800&amp;doi=10.1158/0008-5472.CAN-13-1531&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R43"><span class="element-citation">Wroblewski JT, Nicoletti F, Costa E. Different coupling of excitatory amino acid receptors with Ca2+ channels in primary cultures of cerebellar granule cells. <span><span class="ref-journal">Neuropharmacology. </span>1985;<span class="ref-vol">24</span>:919–21.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/2414684" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=Different+coupling+of+excitatory+amino+acid+receptors+with+Ca2++channels+in+primary+cultures+of+cerebellar+granule+cells&amp;author=JT+Wroblewski&amp;author=F+Nicoletti&amp;author=E+Costa&amp;volume=24&amp;publication_year=1985&amp;pages=919-21&amp;pmid=2414684&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R44"><span class="element-citation">Xifr&#x000f3; X, Mi&#x000f1;ano-Molina AJ, Saura Ca, Rodr&#x000ed;guez-&#x000c1;lvarez J. Ras protein activation is a key event in activity-dependent survival of cerebellar granule neurons. <span><span class="ref-journal">J Biol Chem. </span>2014;<span class="ref-vol">289</span>:8462–72. doi: 10.1074/jbc.M113.536375.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3961671/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24523415" ref="reftype=pubmed&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1074%2Fjbc.M113.536375" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Ras+protein+activation+is+a+key+event+in+activity-dependent+survival+of+cerebellar+granule+neurons&amp;author=X+Xifr&#x000f3;&amp;author=AJ+Mi&#x000f1;ano-Molina&amp;author=Ca+Saura&amp;author=J+Rodr&#x000ed;guez-&#x000c1;lvarez&amp;volume=289&amp;publication_year=2014&amp;pages=8462-72&amp;pmid=24523415&amp;doi=10.1074/jbc.M113.536375&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4387075&amp;issue-id=251407&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li></ul></div></div></div><!--post-content--><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC4387075/pdf/nihms665032.pdf" class="int-view">PDF (664K)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/4387075/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/4387075/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="4387075" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4387075%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="NBDL1uFYMDKNPOpLO14Gp6tpsMVZ7Ew8t3B1pHXGwCsRgHZFsKnJYpxvuaWJyFh5">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4387075%2F&amp;text=Pharmacological%20characterization%20of%20mGlu1%20receptors%20in%20cerebellar%20granule%20cells%20reveals%20biased%20agonism" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4387075%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387075/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC4387075/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/25700650/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC4387075/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/25700650/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC4387075/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/4387075/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC4387075/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
